DPHS Get To Know Us Viewbook by UM Department of Public Health Sciences

THIS IS A PUBLIC HEALTH

MOMENT

University of Miami Miller School of Medicine Department of Public Health Sciences

TABLE OF CONTENTS

4 .............................................................................................About DPHS 6 ........................................................Executive Organizational Chart 8 ....................................................Department Organizational Chart 10 ...............................................................................................Education 12 ..................................................................................................Research 14 .....................................................................................................Service 26 ..............................................................................Faculty Biographies

University of Miami Miller School of Medicine Department of Public Health Sciences

ABOUT DPHS The Department of Public Health Sciences (DPHS) is located in the University of Miami Miller School of Medicine (UMMSM) and is organized into five divisions: Biostatistics, Epidemiology and Population Health Sciences, Health Services Research and Policy, Environment and Public Health, and Prevention Science and Community Health. Currently, there are 42 primary faculty and 74 secondary, voluntary, and emeritus faculty appointments.

MISSION Our mission is to discover strategies that promote health among people, families, communities and environments. We implement this mission in multicultural South Florida, the Americas and beyond, developing leaders who can expand knowledge and translate research into public health policy, practice and service for diverse populations.

RESEARCH DPHS is a leader in research, teaching, and service and is closely aligned with foundational public health values. Department faculty are collaboratively engaged in research across the medical school and the broader University community. Based on data from the Blue Ridge Institute for Medical Research for federal fiscal year 2020, DPHS ranks #4 in National Institutes of Health (NIH) funding within UMMSM. The NIH funding rank for DPHS is favorable relative to other U.S. Public Health Schools (26th out of 68) and departments within Medical Schools (15th out of 46). Additionally, the department ranks #6 in NIH funding within the University of Miami. NIH RANKINGS

DPHS is an innovator in the training of the next generation of public health practitioners and scientists. Current enrollment is at 419 students across a range of master’s and doctoral programs that are accredited under the Council on Education for Public Health (CEPH). These training programs include three doctoral degrees in Biostatistics, Epidemiology, and Prevention Science and Community Health, as well as Master of Public Health, Master of Science in Public Health, and Master of Science degrees in Biostatistics, Climate and Health, and Prevention Science and Community Health. We offer certificates and innovative joint degree programs, including our highly successful four-year MD/MPH program. We also offer joint degrees in Medicine, Law, International Administration, Latin American Studies, and Public Administration. These programs have served as an effective bridge to the Coral Gables Campus, which is located 12 miles from the Medical Campus. Students in the College of Arts and Sciences’ Master of Arts in Global Health & Society degree program also develop an interdisciplinary perspective on global health and may focus their studies on public health tools and methodologies by taking up to 12 public health credits. As part of the Master of Science degree in Climate and Health, students take courses in the department, as well as on the Marine Campus. Currently, DPHS faculty are leading the effort to develop and launch new MS programs in Applied Epidemiology and Environment and Public Health.

INTERNATIONAL, NATIONAL AND LOCAL IMPACT

FFY20

Ranking for NIH funding within the Miller School of Medicine

Ranking for NIH funding compared to other public health schools

Ranking for NIH funding compared to departments within Medical Schools

Ranking for NIH funding within the University of Miami

University of Miami Miller School of Medicine Department of Public Health Sciences

GRADUATE PROGRAMS

The research and service missions of DPHS are synergistically intertwined with its teaching mission. Many students within research programs led by DPHS faculty have conducted faculty-supervised MPH capstone projects, which have led to local, national and international placements in over 30 countries in the past two years alone.

Student-led service projects also impact the greater Miami area, as well as regional efforts in the Caribbean and elsewhere.

MISSION STATEMENT DPHS brings sustainable, positive changes in health by providing an outstanding program of research, teaching and service to educate the next generation of public health leaders who endeavor to discover, test and disseminate solutions to health threats and problems; and translate research into effective practices and sound policies.

INNOVATIVE GLOBAL LEADERS

University of Miami Miller School of Medicine Department of Public Health Sciences

EXECUTIVE COMMITTEE ORGANIZATIONAL CHART DAVID J. LEE, PH.D. Chair, Professor Department of Public Health Sciences

MARGIE JIMENEZ, M.A., CRA Sr. Administrative Officer Department of Public Health Sciences and Comprehensive Drug Research Center

Biostatistics Division Director J. Sunil Rao, Ph.D. Professor, Tenured

Environment & Public Health Division Director John Beier, Sc.D. Professor, Tenured

Prevention Science & Community Health Division Director Adam Carrico, Ph.D. Professor, Tenured

Health Services Research & Policy Division Director Kathryn McCollister, Ph.D. Professor, Tenured

Epidemiology & Population Health Sciences Division Director Jennifer Hu, Ph.D. Professor, Tenured

Graduate Programs Director David J. Lee, Ph.D. Professor, Tenured

MD/MPH Program Director Shirin Shafazand, MD, MS Professor, Clinical Medicine

Public Health Education Director Viviana Horigian, MD, MHA Professor, Educator

University of Miami Miller School of Medicine Department of Public Health Sciences

MARGIE JIMENEZ, M.A., CRA

DAVID LEE, PH.D.

JOHN BEIER, SC.D.

ADAM CARRICO, PH.D.

SHIRIN SHAFAZAND, MD, MS

University of Miami Miller School of Medicine Department of Public Health Sciences

VIVIANA HORIGIAN, MD, MHA

KATHRYN MCCOLLISTER, PH.D.

JENNIFER HU, PH.D.

J. SUNIL RAO, PH.D.

DEPARTMENT ORGANIZATIONAL CHART At a Glance Primary Faculty: 43 Secondary, Voluntary, and Emeritus: 74 Total Faculty: 117 Research/Faculty Support Staff: 71 Graduate Programs/Central Administration: 23

MARGIE JIMENEZ, M.A., CRA

DAVID J. LEE, PH.D.

Total Faculty and Staff: 211

Sr. Administrative Officer Department of Public Health Sciences and Comprehensive Drug Research Center

Chair, Professor Department of Public Health Sciences

Biostatistics J. Sunil Rao, Ph.D. Division Director, Professor, Tenured Primary Faculty FTE: 15 Secondary (0), Voluntary (2), and Emeritus (1) Total Faculty: 18 Research Staff: 14

Environment & Public Health John Beier, Sc.D. Division Director, Professor, Tenured Primary Faculty FTE: 4 Secondary (7), Voluntary (5), and Emeritus (0) Total Faculty: 16 Research Staff: 7

Epidemiology & Population Health Sciences Dr. Jennifer Hu Division Director, Professor, Tenured Primary Faculty FTE: 7 Secondary (11), Voluntary (5), and Emeritus (1) Total Faculty: 25 Research Staff: 10

Hemant Ishwaran, Ph.D. Professor, Tenured Director of Biostatistics Ph.D. Program

Daniel Feaster, Ph.D.

Naresh Kumar, Ph.D.

Professor, Tenured

Professor, Tenured Director of M.S. in Climate

Director of Statistical

and Health Program

Methodology

Scott Brown, Ph.D. Research Associate Professor

WayWay Hlaing, Ph.D. Professor, Educator

Paulo Pinheiro, Ph.D.

Director of Epidemiology

Research Associate

Ph.D. Program

Professor

Taghrid Asfar, MD, MSPH

Ana Palacio, M.D., M.P.H.

Shari Messinger, Ph.D. Professor, Tenured Director of Biostatistics Core

Lily Wang, Ph.D.

Alberto Caban-

Associate Professor,

Martinez, Ph.D., DO, MPH

Tenured

Associate Professor, Tenure-Earning

Research Assistant

Professor of

Professor

Clinical Medicine

James Shultz, Ph.D., MS

Victor Rosenthal, M.D.

Associate Professor,

Research Associate

Educator

Professor

Assistant Provost for Research Integrity Xi (Steven) Chen, Ph.D. Professor, Tenured Director of SCCC Biostatistics

Deputy Director, Isildinha Reis, Ph.D. Research Professor

and Bioinformatics CORE

MD/MPH Program

Core

Tulay Koru-Sengul, Ph.D. Research Associate

Raymond Balise, Ph.D.

Professor

Research Assistant

TBA

Lead Faculty MSPH

Professor

Associate/Full Professor, Tenure Track

Director of MS in Biostatistics Program

Daniel Diaz-

Min Lu, Ph.D.

Panchon, Ph.D.

Research Assistant

Professor

Yue Pan, Ph.D. Deukwoo Kwon, Ph.D.

Research Assistant

Professor

TBA

Yuguang Ban, Ph.D.

Professor

Research Assistant

SCCC/DPHS

Professor

University of Miami Miller School of Medicine Department of Public Health Sciences

Faculty FTE

FY22

Tenured: 16 Tenured Track: 4 Research: 15 Educators: 7 TBA Faculty Positions: 6 Total: 48

Health Services Research & Policy Kathryn McCollister, Ph.D. Division Director, Professor, Tenured Primary Faculty FTE: 8 Secondary (12), Voluntary (11), and Emeritus (1) Total Faculty: 32 Research Staff: 21

Julio Frenk, MD, MPH, Ph.D. Professor, Tenured

Felicia Knaul, Ph.D. Professor, Tenured

Prevention Science & Community Health Adam Carrico, Ph.D. Division Director, Professor, Tenured Primary Faculty FTE: 8 Secondary (6), Voluntary (11), and Emeritus (1) Total Faculty: 26 Research Staff: 8

Tatiana Perrino, Psy.D.

Eric Brown, Ph.D.

Professor, Educator

Associate Professor,

Chair, Curriculum

Educator

Committee MD/MPH and MPH

Director of Prevention

Associate Provost for Faculty

Science Ph.D. Programs

Strategic Planning, Administration, Finance, Operations, Grants and Contracts, Graduate Programs and Communications/Media & Marketing Margie Jimenez, M.A., CRA Senior Administrative Officer Department of Public Health Sciences and Comprehensive Drug Research Center

Strategic Planning

Finance

Graduate Programs

Grants & Contracts

Development Associate Dean for UM Graduate School Howard Liddle, Ed.D.

Jose Szapocznik, Ph.D.

Professor, Tenured

Sara St. George, Ph.D. Assistant Professor, Tenure-Earning Director of Prevention

Mariano Kanamori, Ph.D.

Student Enrollment: 419

Science M.S. Programs

Assistant Professor, Tenure-Earning Viviana Horigian, MD, MHA

Nelson Arboleda, MD, MPH

Professor, Educator

Audrey Harkness, Ph.D.

Associate Professor,

Director of Public Health

Research Assistant

Educator

Professor

Education Director Latin America

Communications/Media & Marketing

Operations (Human Resources, Faculty Affairs, and Facilities)

Amy Otto, Ph.D. Research Assistant Professor

TBA

Tyler Bartholomew, Ph.D.

Associate/Full Professor,

Research Assistant

Research Track

Professor

Patricia Moreno, Ph.D. Assistant Professor, Tenure Earning TBA Associate/Full Professor, Tenure Track

TBA

Associate Professor,

Online Programs,

Educator Track

Professor Educator

University of Miami Miller School of Medicine Department of Public Health Sciences

ACADEMIC DEGREES

MASTERS DEGREES MASTER OF PUBLIC HEALTH (MPH) • • • • • • •

Accelerated Generalist Biostatistics Epidemiology and Population Health Sciences Environment and Public Health Health Services Research and Policy Prevention Science and Community Health

MASTER OF SCIENCE IN PUBLIC HEALTH (MSPH) • • •

Generalist Epidemiology Health Services Research and Policy

MASTER OF SCIENCE IN BIOSTATISTICS (MS BST) MASTER OF SCIENCE IN CLIMATE AND HEALTH (MS CH) MASTER OF SCIENCE IN PREVENTION SCIENCE AND COMMUNITY HEALTH (MS PSCH)

DOCTORATES DOCTOR OF PHILOSOPHY IN BIOSTATISTICS (PhD BST) DOCTOR OF PHILOSOPHY IN EPIDEMIOLOGY (PhD EPI) DOCTOR OF PHILOSOPHY IN PREVENTION SCIENCE AND COMMUNITY HEALTH (PhD PSCH)

JOINT DEGREES DOCTOR OF MEDICINE/MASTER OF PUBLIC HEALTH (MD/MPH) • •

School of Medicine Department of Public Health Sciences

DOCTOR OF MEDICINE/DOCTORATE IN BIOSTATISTICS, EPIDEMIOLOGY, OR PREVENTION SCIENCE AND COMMUNITY HEALTH • •

School of Medicine Department of Public Health Sciences

JURIS DOCTOR/MASTER OF PUBLIC HEALTH (JD/MPH) • •

School of Law Department of Public Health Sciences

MASTER OF PUBLIC ADMINISTRATION/MASTER OF PUBLIC HEALTH (MPA/MPH) • •

College of Arts and Sciences Department of Public Health Sciences

MASTER OF ARTS IN INTERNATIONAL ADMINISTRATION/MASTER OF PUBLIC HEALTH (MAIA/MPH) • •

College of Arts and Sciences Department of Public Health Sciences

BACHELOR OF SCIENCE IN PUBLIC HEALTH/MASTER OF PUBLIC HEALTH (4+1 BSPH/MPH) • •

School of Nursing and Health Studies Department of Public Health Sciences

ACCREDITATION DPHS has maintained continuous accreditation by CEPH (Council on Education for Public Health) since 1982 and is currently accredited through 2021. After the last site visit in 2014, DPHS received accreditation for a full seven years. DPHS will be submitting the next self-study report in 2020, with an expected site visit in Fall 2021. University of Miami Miller School of Medicine Department of Public Health Sciences

20% IN TUITION SCHOLARSHIP AWARDS FOR MPH AND MSPH STUDENTS COMPLETING A 45-CREDIT DEGREE PROGRAM STARTING IN THE SPRING 2022 AND FALL 2022 SEMESTERS.

DEGREES AND PROGRAMS IN DEVELOPMENT SELECTIVE ONLINE COURSES FOR PRACTITIONERS DOCTORATE IN PUBLIC HEALTH PROGRAM (DR.PH.) ONLINE MPH CERTIFICATE MPH/MBA PROGRAM EXECUTIVE MPH PROGRAM

LATIN AMERICA MD CERTIFICATE PROGRAM IN PUBLIC HEALTH CERTIFICATES IN: • • • • •

Biostatistics Environment and Public Health Epidemiology and Population Health Sciences Health Services Research and Policy Prevention Science and Community Health

CERTIFIED IN PUBLIC HEALTH CREDENTIAL The CPH, offered through the The National Board of Public Health Examiners, is a credential that demonstrates knowledge and commitment through continuing public health education. DPHS offers a pre-mock exam, a boot camp, and a post-mock exam to prepare students for the official CPH exam. The opportunity is available for students who are enrolled in any graduate programs within DPHS. University of Miami Miller School of Medicine Department of Public Health Sciences

RESEARCH Through innovative public health research, DPHS faculty investigates determinants of different diseases, as well as effective prevention and intervention strategies that will ultimately advance population health through training and dissemination of groundbreaking discoveries. Currently, there are 42 primary faculty involved in highly interdisciplinary translational research and education, as well as an active group of 74 secondary, voluntary, and emeritus faculty from across the University, the community and beyond who are leaders in their respective fields. DPHS faculty are collaboratively engaged in research across the medical school and the broader University community. They also work on research projects in countries throughout South America, the Caribbean, the Middle East, and Africa. These programs provide new understanding and effective dissemination strategies that result in important and timely impacts on the health of populations locally, nationally, and internationally. Based on data from the Blue Ridge Institute for Medical Research for federal fiscal year 2020, DPHS ranks #4 in National Institutes of Health (NIH) funding within UMMSM. The NIH funding rank for DPHS is favorable relative to other U.S. Public Health Schools (26th out of 68) and departments within Medical Schools (15th out of 46). Additionally, the department ranks #6 in NIH funding within the University of Miami.

University of Miami Miller School of Medicine Department of Public Health Sciences

IN PUBLIC HEALTH, SOCIETY IS

OUR PATIENT

Grants and Contracts FY2019 - FY2022 20,000,000

18,000,000

16,000,000

$16,076,475

$14,677,566

14,000,000 $13,001,462

$13,000,000

12,000,000

10,000,000

8,000,000

6,000,000

FY2019

University of Miami Miller School of Medicine Department of Public Health Sciences

FY2020

FY2021

FY2022 PROJECTION

SERVICE FACULTY NEW PROJECTS AND AWARDS •

Dr. Lily Wang was selected as a reviewer for the Genetics of Health and Disease (GHD) Study Section meeting held on June 29 to 30, 2020 by NIH Center for Scientific Review. In this role she helped with reviewing grant applications involving the discovery, application and interpretation of genetic, genomic and epigenomic variations in different human diseases. In collaboration with Dr. Eden Martin and Dr. Brian Kunkle from Human Genetics, Dr. Wang also served as a MPI for the five year R01 project “Integrative Genomic Approaches for Understanding Sex Differences in AD.”

•

Dr. Tatiana Perrino developed and co-led a sixsession Teaching Academy for Ph.D. students and Post-doctoral Fellows across University of Miami Schools and Colleges. This selective academy is sponsored by the UM Graduate School, and prepares participants for academic careers that involve teaching. The academy delves into course design, active learning and student engagement, teaching with technology, as well as assessment of learning. The third cohort of fellows will enroll and participate in 2020. Dr. Xi Steven Chen is a major contributor for the identification of the six major triplenegative breast cancer (TNBC) subtypes and the corresponding gene signatures. He is the developer of the web-based software “TNBCtype”, which has been widely used by the breast cancer research community. Dr. Chen has been the PI of multiple National Cancer Institute (NCI) R01s since 2012, and he has been participating NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC) conducting integrative proteogenomic data analysis for multiple cancer types.

•

Dr. John Beier led the Research and Training projects for the Miami-Dade Mosquito Control Division, which was supported by a CDC grant: Southeast Regional Center of Excellence in Vector-Borne Disease: The Gateway Program. Dr. Beier’s joint work with MD Mosquito Control better prepares them to maintain quality mosquito control operations throughout the county. It also improved their capacity to respond to mosquitoborne disease outbreaks (e.g., Zika, dengue, chikungunya, Yellow Fever).

•

Dr. Beier and his team investigated plant sources for sugar feeding, the timing of sugar-feeding, movement of sugar-fed mosquitoes from outdoors to inside houses, seasonal variation, and how vectors adapt to environmental plant sugar sources. This research facilitated the development of attractive toxic sugar baits (ATSB), which has been approved by WHO Vector Control Advisory Group (VCAG). Currently, ATSB is being tested in cluster randomized epidemiological trials in Mali, Kenya, and Zambia

•

Dr. Scott C. Brown and Dr. José Szapocznik, leading their Built Environment Behavior and Health Research Group (BEBHRG), were awarded a grant by the National Heart, Lung, and Blood Institute (NHLBI) for a three-year, multi-disciplinary study on neighborhood greenness and metabolic syndrome among Hispanics. The study is an ancillary study of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), which was initiated in 2006, by Dr. Neil Schneiderman, PI, as a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development of disease, and to identify risk factors playing a protective or harmful role in Hispanics/Latinos.

“Empowering our students to transform lives and inspire them to serve our global community.” — Dean Ford University of Miami Miller School of Medicine Department of Public Health Sciences

SERVICE CONTINUED

They also led the BEBHRG in the award of grant by the Ed and Ethel Moore Alzheimer’s Disease Research Program administered by the Florida Department of Health for a two-year study on the Impacts of Neighborhood Greenness & Greening Initiatives on Alzheimer's Disease in Medicare Beneficiaries.

•

The team obtained and analyzed input from academic, professional, and political leaders from around the world regarding international principles that can strengthen collaboration around global public health protection, strategies for encouraging countries to engage in pandemic prevention, preparedness and response, and to establish an effective global health security compact. The recommendations emerging from this work, which primary focus on issues of governance of an international body to coordinate global pandemic protection, will be presented at the 2020 Global Summit of UNITE, the Global Parliamentarian Network to End Infectious Diseases. The team is also working with the World Leadership AllianceClub de Madrid. The team will work with both of these international organizations to encourage implementation of the recommendations.

•

Dr. Szapocznik, Dr. Jorge Saavedra, and Dayana Rojas investigated the association between the social determinants of health and HIV viral load control among persons living with HIV in Miami-Dade County. A first study conducted at the ZIP code-level found that zip codes with the lowest socioeconomic status, lowest education and least access to health insurance were the most likely to have high rates of uncontrolled HIV viral load (defined as out of treatment or detectable HIV viral load). These findings, published in the Journal of Racial and Ethnic Health Disparities, also revealed alarmingly high rates of uncontrolled HIV viral load among Black/African American persons living with HIV.

BEBHRG members Dr. William Aitken, M.D., and Prof. Joanna Lombard, M.Arch., delivered presentations at the 2020 convenings of the Active Living Research Conference and American Heart Association (W.A.), and the Society for Prevention Research (J.L.), respectively. Dr. Brown and Committee Vice-Chair and BEBHRG member Joanna Lombard hosted the Health & Built Environment Committee, Consortium for Healthier Miami-Dade County, Zoom sessions, featuring the work of Joseph Minicozzi of Urban3 on Redressing Redlining. •

In collaboration with the AIDS Healthcare Foundation (AHF) Global Public Health Institute at the University of Miami, Dr. José Szapocznik leads an interdisciplinary team of investigators (Jorge Saavedra, Nelson Arboleda, Johnathan Duff, Jacob Batycki, Annie Liu and Kendra Morancy) to create a Global Public Health Security Convention for the 21st Century.

University of Miami Miller School of Medicine Department of Public Health Sciences

SERVICE CONTINUED •

While Black/African Americans represent 18.2% of the Miami-Dade County population, they represented 42% of the population of persons living with HIV, and 54% of population with uncontrolled HIV. A follow-up study has been awarded to Dr. Rojas by the NIMHD/NIH Center for Latino Health Research Opportunities (CLaRO) at the University of Miami. To increase the accuracy of results, this follow-up study will use individual-level data for all people living with HIV in Miami-Dade County, again investigating the impact of social determinants of health on uncontrolled viral load. The study will permit the identification of specific social and environmental characteristics that if modified could reduce health disparities, and the overall rates of uncontrolled HIV viral load in Miami-Dade County.

•

Dr. Adam Carrico is leading a project called CRUSH. There is extensive evidence from his research team, as well as others that HIV-positive persons who use stimulants such as meth experience profound damage to the immune system, even when virally suppressed. CRUSH is a perspective cohort study that is looking to see if cooccurring methamphetamine (meth) use, and HIV infection will have synergistic, detrimental consequences for infection with the novel coronavirus (SARS-CoV-2) infection among men who have sex with men (MSM). A total of 200 MSM recruited from the South Florida community to complete assessments over 6 months to examine the bio-behavioral correlates of SARS-CoV-2 prevalence and incidence.

University of Miami Miller School of Medicine Department of Public Health Sciences

•

Dr. Carrico is also leading an intervention called ARTEMIS. In a recent study, methamphetamine-using men had five-fold greater odds of repeat prescription for postexposure prophylaxis (PEP) and a three-fold greater rate of HIV seroconversion. This underscores the urgent need for PrEP to achieve meaningful reductions in HIV incidence in stimulant-using sexual minority men. Affect Regulation Treatment to Enhance Medication Intervention Success (ARTEMIS) is a positive effect intervention delivered during smartphone-based Contingency Management (CM) for directly observed PrEP doses. The primary aim of this study is to achieve durable and clinically meaningful improvements in the proportion of participants at risk for HIV acquisition over 12 months.

•

Dr. Sara St. George has two funded studies that aim to develop and evaluate smartphonedelivered lifestyle interventions in ethnic minority populations in South Florida. One of these projects, funded by the National Heart, Lung, & Blood Institute aims to improve the physical activity and diet of Hispanic parents and their 12-15 year-old adolescents. The other, funded by the V Foundation for Cancer Research, aims to develop and evaluate a multigenerational digital lifestyle intervention for female cancer survivors and their families.

SERVICE CONTINUED •

The L&L Copeland Foundation sponsored an education-research project led by Dr. WayWay M. Hlaing, titled, “Renewed Focus on Epidemiology Education”. This is the first study that collected doctoral-level epidemiology competencies and other pertinent information from PhD in Epidemiology Program Directors or relevant leaders from accredited schools and programs of public health (SPPH). The study will be published in the American Journal of Epidemiology (AJE) in 2020.

•

Dr. Harkness is conducting the DÍMELO study, a project seeking to identify barriers and facilitators to Latinx sexual minority men’s use of preexposure prophylaxis, HIV testing, and behavioral health services in Miami-Dade County. The project is funded by pilot awards from the Miami Center for AIDS Research and UM Center for Latino Health Research Opportunities.

•

Dr. Harkness developed the Pandemic Stress Index (Harkness et al., 2020, AIDS and Behavior) to assess the impact of COVID-19 on individual’s psychosocial and behavioral well-being. The PSI is now available in eight languages (English, Spanish, Turkish, Italian, Mandarin, Creole, Arabic, and Portuguese) and can be downloaded from the Center for Latino Health Research Opportunities’ Measures Library: https://elcentro. sonhs.miami.edu/research/measures-library/ covid-19/index.html.

•

Supported by the American College of Epidemiology and Division of Epidemiology, Dr. Hlaing, co-lead the education project to expand ethics in epidemiology and public health curriculum resources.

•

Dr. Hlaing served on various grant review panels (special emphasis R01 panel, loan repayment program reviews) for the NIH's National Institute on Minority Health and Health Disparities (NIMHD).

•

Dr. Hlaing was invited to present on the PhD/postdoctoral level competencies in epidemiology at the 2nd International Consortium on Teaching Epidemiology at University of Zurich in January 2020. She is a member of the International Consortium that consists of epidemiologists and epidemiology trainees from 19 countries around the world.

Dr. Tali Elfassy was selected as a 2020 Health Disparities Research Institute (HDRI) Scholar. The HDRI, hosted by the National Institutes of Health, National Institute on Minority Health and Health Disparities, took place virtually August 3rd to 6th 2020. The goal of the HDRI program is to facilitate health disparities research and support research independence among early career investigators.

•

Dr. Elfassy was selected as a finalist for the American Heart Association Sandra A. Daugherty Award for Excellence in Cardiovascular Disease or Hypertension Epidemiology and Prevention. The award was announced at the American Heart Association Epidemiology and Prevention/ Lifestyle and Cardiometabolic Health conference on March 5th 2020.

•

Dr. Elfassy was awarded a one year pilot award project titled, “The NOVA dietary framework and

•

Dr. Audrey Harkness is providing a “Mental Health and Self Care for Frontline Staff” Training as part of the Florida Department of Health’s 2020 501 Update for Miami-Dade County HIV Test Counselors. Dr. Harkness is also funded by a Copeland Foundation award to assess Miami-Dade HIV Test Counselors’ experiences referring clients to pre-exposure prophylaxis and behavioral health services in the context of their HIV test counseling sessions.

University of Miami Miller School of Medicine Department of Public Health Sciences

SERVICE CONTINUED its association with cardiometabolic disease and mortality among ethnic/minority older US adults.” This pilot award is funded by the Rutgers University Asian Resource Centers for Minority Aging Research (RCMAR). •

Dr. Elfassy was appointed as a member of the Meet Group’s Safer Dating Scientific Advisory Board. The purpose of this board is to provide sound scientific guidance for safely dating during the COVID-19 pandemic.

•

Dr. Paulo Pinheiro is a Principal Investigator in a Bankhead-Coley project on etiology, mortality and survival for lung and liver cancers by Hispanic and African-descent subgroups in Florida including Cubans, Puerto Ricans, Dominicans. Mexicans and Afrocaribbeans. He is also an investigator in the NCI-funded ENCLAVE study, which analyzes the effect of living in racial-ethnic in states across the US on cancer incidence and survival. He is an active member of the African and Caribbean Cancer Consortium (AC3).

•

For Latin America, Dr. Pinheiro has ongoing partnerships for a study on cervical cancer survival with the Javeriana University in Bogota Colombia and a study on Endometrial cancer type II incidence and prognosis with the University des Antilles in Martinique.

•

Between December 2019 and March 2020, the southern coast of Puerto Rico experienced a series of devastating earthquakes that destroyed homes and businesses. Many affected families relocated to Central Florida. With funding from the University of Miami Institute for the Americas, Dr. Schwartz and his team are also conducting a survey study of 80 adult earthquake survivors. They are asking about exposure to Hurricane Maria and the earthquakes, mental health, reactions to COVID-19, and life after relocation. They will also conduct virtual focus groups with participants and will hold a community partner event to develop programs for this traumatized population.

University of Miami Miller School of Medicine Department of Public Health Sciences

•

Dr. Naresh Kumar is working on a University of Miami-led project titled, "Childhood Asthma in Urban Settings & Environmental Exposure (U-CAUSE)". Asthma is a complex multifactorial chronic disease. Genetic, social, dietary and environmental factors play roles in the pathogenesis, progression and persistence of the disease. While there has been great strides in genotyping and phenotyping of the disease, (atopic) asthma morbidity especially remains challenging especially in the underserved and understudied minority populations, such as in MiamiDade, nation’s one of most ethnically and economically diverse counties where lifetime adolescent asthma prevalence is 21.4% and highest among Hispanic and nonHispanic African American adolescents. U-CAUSE aims to address this research gaps by conducting and supporting pediatric asthma clinical and biomedical research in MiamiDade where allergen exposure (indoor mold and outdoor pollen) is high year around due to its tropical climate.

•

Dry eye (DE), characterized by a myriad of signs, such as decreased tear production, increased evaporation, and inflammation, and symptoms, such as pain, blurry vision and dryness, is a debilitating disease that affects quality of life. Many patients have persistent symptoms, because the available clinical therapies are not adequate to manage DE. Thus, managing DE requires solutions (i.e. beyond individual- level clinical interventions). An emerging literature suggests that environmental conditions can contribute to the onset and persistence of DE. Our microenvironment is a complex mixture of particulate matter (PM), gaseous air pollutants and allergens. However, individual specific data on microenvironment are not available. Dr. Kumar is working on a project that will test two novel hypotheses: 1) the clinical manifestations, measured by the types and severity of different measures of DE, vary with respect to types, levels and sources of air pollutants, allergens, humidity and temperature, specifically, exposure to PM, bioaerosols and gaseous pollutants is associated with epithelial disruption (ED), inflammation and evaporative tear deficiency (ETD), respectively; 2) DE signs are more strongly associated with indoor relative to outdoor air pollution, as we spend more time indoors and our indoor exposure dominates our total exposure to microenvironmental conditions.

SERVICE CONTINUED •

Hurricane Maria, the 10th most intense hurricane, caused catastrophic damage in Puerto Rico (PR). While accounting continues for loss of life and damaged infrastructure, media reports and our field observations suggest that communities may be subject to elevated exposure to environmental contaminants after the hurricane due to increased community reliance on local resources including drinking water from the local creeks and fishing and harvesting seafood from the local bays. Dr. Kumar has found the second highest concentration of polychlorinated biphenyls (PCB) in the US in the sediment of Guánica Bay, located in Southern West part of PR. The high levels are of particular concern after the hurricane because of the potential redistribution of PCB within populated areas due to storm surge and because of the increased community reliance on the bay and nearby areas for harvesting fish and seafood due to lack of meats and seafood available for purchase in grocery stores and markets. For the past six years, Dr. Kumar and his team has been pursuing collaborative research with different stakeholders in Guánica Municipality, and engaging them in the dissemination of information resulting from this research. Their preliminary data before and after the hurricane suggest that communities living around the bay still lack awareness about the PCB contamination of the bay and continue to harvest seafood and fish from the area. Capitalizing on their partnership with the local stakeholders, support from their community partners, and solid baseline sediment and fish data collected in 2014, 2015 and 2016 and community survey data collected in 2014, 2015 and very recently after Hurricane Maria in November 2017, Dr. Kumar is working on a project that will a) examine the impact of Hurricane Maria on PCB redistribution in and around Guánica Bay and b) assess changes in community exposure to PCBs through inhalation and consumption of contaminated seafood and fish.

University of Miami Miller School of Medicine Department of Public Health Sciences

•

Eyes are chronically exposed to air pollutants that are shown to adversely affect the ocular surface. However, severity of these effects vary with respect to air pollution level, its type and composition. Given an unabated increase in air pollution in low- and middle-income countries (LMIC), these countries bear ~ 90% of air pollution disease burden as estimated by WHO. However, this burden does not include ocular surface disorders (OSD), including dry eye (DE), with vision impairment and associated disability. Until recently, most air pollution health research has focused on cardiopulmonary disease. Although emerging literature shows a link between air pollution and OSD, our knowledge of the burden of air pollution on the ocular surface and its associated OSD is still limited, especially in LMIC, which have been witnessing hazardous levels of air pollution in recent decades. Capitalizing on Dr. Kumar's current research (supported by NEI: R01EY026174) on air pollution in Miami and Baltimore, and his novel methodology to directly assess air pollution burden on the ocular surface, our interdisciplinary team from All India Institute of Medical Sciences (AIIMS) and University of Miami (UM), he and his team will address this research gap by examining the role of air pollution in OSD in Delhi, declared as the most polluted city in the world. The project will test two novel hypotheses that: 1) clinical manifestations, measured by the types and severity of different measures of OSD, vary with respect to types, levels and sources of air pollutants, allergens, humidity and temperature, specifically, exposure to PM, bioaerosols and gaseous pollutants is associated with epithelial disruption (ED), inflammation and evaporative tear deficiency (ETD), respectively; 2) OSD signs and symptoms are more strongly associated with indoor relative to outdoor air pollution, as we spend more time indoors and our indoor exposure dominates our total exposure to microenvironmental conditions.

SERVICE CONTINUED •

•

Hurricanes are the most devastating natural disasters that dramatically change the physical landscape and modify socio-physical environment. Direct environmental impacts, such as flooding and infrastructure damage and associated mortality burden have been subject to accounting. However, their long-term impacts on changes in environmental exposure and associated disease burden go unnoticed Hurricane Maria and Irma resulted in more than 3,000 deaths, and full recovery in both Puerto Rico and South Florida is far from complete even more than a year after the hurricanes. However, morbidity or pregnancy outcomes burdens due to elevated exposure to environmental pollutants have not be subject to accounting. Our preliminary data from OneFlorida Clinical Research Consortium (OneFL) of healthcare network that serves more than ~70% Floridians suggests a 4.3% (or 11,114 patients) show an increase in emergency room and clinical visits six months after hurricane Irma, and our team detected hazardous concentrations of environmental pollutants in Puerto Rico in the aftermath of Hurricane Maria and an increase in community reliance on seafood from the contaminated bay. Grounded on Dr. Kumar's preliminary data and first-hand field observations in Puerto Rico (PR) and South Florida, he will work on a project where he and his team hypothesize that mortality, morbidity and adverse birth outcome burdens of hurricanes persist for months to years, and non-life threating disease burden of hurricanes is subjects to underreporting. According to the World Health Organization, air pollution alone accounts for more than 4 million deaths annually due to cardiopulmonary diseases worldwide. Low and middle income countries (LMIC) account for 90% of this disease burden because of dramatic increase in ambient air pollution in recent years. This disease burden is likely to be much higher than that reported, because emerging research suggests that air pollution transport goes beyond cardiopulmonary systems. Air pollution is a complex mixture of airborne particles and gases. The toxicity of air pollutants and their target organs depend on sources of air pollution, concentration of air pollution, and particle size, its biological and chemical characteristics. Given sources, levels and types of air pollutants in LMIC and high

University of Miami Miller School of Medicine Department of Public Health Sciences

income countries (HIC) vary dramatically, disease specific burden associated with air pollution also varies across LMIC and HIC. Dr. Kumar and his team are leading a project that will support transdisciplinary and international research and training to understand the types and severity of diseases associated with the levels and types of indoor and outdoor air pollutants found in LMIC and HIC to guide personalized interventions to mitigate and manage air pollution disease burden. •

Dr. Taghrid Asfar has recently been awarded the Florida Department of Health’s Esther King Biomedical Research Award. The award supports research initiatives that address the health care problems of Floridians in the areas of tobacco-related cancer, cardiovascular disease, stroke, and pulmonary disease. Dr. Asfar and a team of health communication experts will work on a five-year project to adapt waterpipe health warning labels, specifically targeting youth in Florida. Waterpipe smoking – also known as hookah – has become a leading tobacco-use method across the United States, which may be fueled by the widespread misperception that it is not as harmful as cigarettes.

•

The Florida Node Alliance, one of the longest and highest-funded programs housed at and managed by the University of Miami Miller School of Medicine, has been renewed for an additional five years. The node is a 20-year, $73.7 funded node of the National Institute on Drug Abuse Clinical Trials Network (CTN) framework, which consists of sixteen nodes. The CTN framework links a variety of treatment providers and patient populations throughout the country. The nodes allow the CTN to provide a broad and powerful infrastructure for rapid, multi-site testing of promising science-based therapies and the subsequent delivery of these treatments to patients in a variety of treatment settings. In the five-year renewal period, the Florida Node

SERVICE CONTINUED Alliance aims to apply their expertise in implementation science, data science, and the use of electronic health records to promote learning health care systems that build on precision medicine principles by implementing and refining methods to predict individual response to treatment. Public health experts who serve as principal investigators of the Florida Node Alliance include Dr. Jose Szapocznik, Dr. Daniel Feaster, Dr. Lisa Rosen-Metsch, Ph.D., dean of the Columbia University School of General Studies and professor of Sociomedical Sciences at the Columbia University Mailman School of Public Health. Previously, Dr. Rosen-Metsch was with the Miller School of Medicine. Dr. Viviana Horigian, serves as the executive director of the node. •

•

Dr. Kathryn McCollister is the Director of the Methodology Core for the recently renewed NIDA-funded P30 Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH; cherishresearch.org). The Methodology Core works to highlight the multidisciplinary nature of substance use disorder (SUD) research, and the importance of economic evaluation research as a core component to this field. CHERISH Methodology Core focuses on guiding researchers in the design, implementation, and interpretation of economic analyses of substance use disorder, HCV, and HIV interventions, as well as on developing and applying methods that support economic evaluations of individual and system-level interventions. Dr. McCollister is leading an economic evaluation of the Leveraging Safe Adults (LeSA) project funded under the NIH Opioid Use Disorder Prevention Initiative, one of the research consortiums housed within the NIH Helping End Addiction Long-term (HEAL) portfolio. LeSA is led by researchers at Texas Christian University, and will adapt and test the evidence-based Trust-based Relational Intervention (TBRI) in preventing opioid initiation and escalation for justice-involved

University of Miami Miller School of Medicine Department of Public Health Sciences

older adolescents. Dr. McCollister will conduct a costeffectiveness analysis comparing TBRI Training only, TBRI with structured coaching, and TBRI with adaptive coaching in preventing opioid initiation/use and in reducing public health and public safety costs. •

Dr. Felicia M. Knaul, with experts from the Miller School of Medicine's Department of Public Health Sciences, UM's College of Arts and Sciences and School of Communication, organizations across the country and leading researchers from Mexico, created and shared a new tool that will help access this information. The tool, officially called the State-Level Observatory for the Containment of COVID-19, presents a daily portrait on the extent of social distancing measures adopted by state governments in Latin America, in accordance with international recommendations, the timeliness of their adoption, and the population’s response in terms of reduced mobility. Mexico, for example, has entered the most critical phase of COVID-19 Phase 3 involves maximum intensification of measures to decrease virus transmission and deaths. Now more than ever, it is critical to have accurate and timely information on the measures to contain the disease, as well as to know whether the population is complying with the measures.

•

Dr. Knaul is among 77 new fellows honored for their impact on health sciences. Dr. Knaul has held senior government posts in Mexico and Colombia and worked for bilateral and multilateral agencies including the World Health Organization, the World Bank, and UNICEF. In 2017, she was inducted into the National Academy of Medicine of Mexico along with University of Miami President Julio Frenk.

SERVICE CONTINUED •

Dr. Julio Frenk was one of the 10 Hispanic pioneers in medicine recognized by the Association of American Medical College. The inspiring leaders have launched advances in medicine and research that led to Nobel Prizes, life-changing cures, and better care for millions of people.

University of Miami Miller School of Medicine Department of Public Health Sciences

WE ARE...WORLDWIDE

PUBLIC HEALTH

University of Miami Miller School of Medicine Department of Public Health Sciences

DPHS FACULTY DPHS is an academic center of excellence that strives to improve the health of the public – one community at a time – through research, education, and service. We promote an environment of learning and inquiry, stressing the scientific method as a way of building knowledge about common pathways that affect health. DPHS faculty ask provocative questions that challenge the status quo, build new models to test, and encourage students to conceive innovative ways to advance the field and bring effective solutions to communities that need them. Our highly qualified, experienced and diverse faculty maintain an intimate, hands-on and personal approach. In addition, we combine research and training with service and interventions to translate our discoveries into policy and practice.

University of Miami Miller School of Medicine Department of Public Health Sciences

FACULTY BIOGRAPHIES Nelson Arboleda, MD, MSPH, is an Associate Professor of Global Health spearheading courses in our Department of Public Health Sciences that provide students insights into global public health challenges faced primarily in developing countries. Through his subject matter expertise, he introduces and mentors students on public health, focusing on addressing global health outbreaks & priorities, building stronger-sustainable health systems & economies, and promoting health equity. Dr. Arboleda is the Director of the Office of the Americas within the Secretary’s Office at the Department of Health and Human Services. In this role he serves as the Secretary’s senior point of contact for interaction with the Americas region, which includes North, Central, South America and the Caribbean. In his previous role, as the Country Director at the Centers for Disease Control and Prevention in the Dominican Republic (CDC-DR), he led the overall efforts of CDC's programs as they relate to PEPFAR, vector-borne diseases, pandemic and seasonal influenza, emerging infectious diseases (Zika, Chikungunya), outbreak investigations, HIV/AIDS, Tuberculosis, emergency preparedness and response, laboratory systems and migrant health. Prior to this position, he was the CDC Regional Director in Central America (based in Guatemala City from 2009-2015) where he led an integrated approach to unify the US government’s investments in global health and established the five-year partnership framework within the US President’s Emergency Plan for AIDS Relief (PEPFAR). This strategy was jointly implemented with the Ministers of Health and the Commission of Ministries of Health of Central America (COMISCA). Dr. Arboleda received his training in Public Health at the University of Miami and the Harvard Kennedy School of Government and joined the CDC in 2004 as an Epidemic Intelligence Service (EIS) officer with the Bioterrorism Preparedness and Response Program within the National Center for Infectious Diseases. He has worked with the National Center for Preparedness, detection, and Control of Infectious Diseases (CDC) leading the Vaccine Safety Office’s University of Miami Miller School of Medicine Department of Public Health Sciences

efforts on Pandemic Preparedness and Emergency Response; as well as steering the Vaccine Adverse Event Reporting System (VAERS) in conjunction with the FDA. His global health assignments include a secondment to WHO with the polio eradication initiative in Madhya Pradesh, India; the consolidation of the national health surveillance system in Honduras; as a program development delegate in Venezuela and Colombia with UNICEF, and injury and violence prevention efforts in Bosnia-Herzegovina. He was also selected as the Commander of the Zika Unified Command Group (UCG) in Puerto Rico under the National Security Council (NSC) at the White House. He has published, authored and co-authored numerous articles in various scientific fields; and has received multiple awards, including the “Rock of the Month” award by CDC’s Chief Science Officer. Field of Interest: Global Health Curriculum Vitae Research Publications Taghrid Asfar, MD, MSPH, is a Research Assistant Professor of Epidemiology in DPHS at UMMSM, and a Member at the Sylvester Comprehensive Cancer Center. She is also a member of the founding team of the Syrian Center for Tobacco Studies, a pioneer-research capacity-building institution in the Middle East. She has extensive experience in tobacco control research nationally and internationally, including epidemiological studies of tobacco use, randomized clinical trials of behavioral smoking cessation interventions, and tobacco policies and regulations. She has published numerous scientific reports in prestigious journals (e.g. Cochrane review, Tobacco Control, and Addiction). Currently, as part of her efforts on her NCI R21 grant, Dr. Asfar is testing a novel worksite smoking cessation intervention for Hispanic construction workers in South Florida. She also serves as a Co-Investigator on a smoking cessation project funded by the Florida Department of Health James and Esther King which aims at addressing racial/ethnic tobacco health disparities via group interventions. Dr. Asfar has been recently awarded an NIH R01 grant entitled “Translating 27

FACULTY BIOGRAPHIES CONTINUED Evidence and Building Capacity to Support Waterpipe Control in the Eastern Mediterranean.” This project aims to develop and test the effectiveness of waterpipe-specific health warning labels targeting young adults in the Middle East (Tunisia and Lebanon). Field of Interest: Tobacco Policies & Regulations Curriculum Vitae Research Publications Raymond Balise, Ph.D., is an Assistant Professor of Biostatistics in the Miller School of Medicine’s Department of Public Health Sciences at the University of Miami (UM). Prior to joining UM, he worked at Stanford University School of Medicine for 17 years as a Biostatistician and Senior Lecturer, as well as serving as the Biostatistics Programmer Coordinator and Project Director for the Statistical Programming Group, Spectrum. He is an award-winning lecturer who has developed and taught classes such as Data Management and Statistical Programming, Survey of Statistical Computing, Medical Biostatistics, Case Studies in Biostatistics, and Data Science and Machine Learning. He is the coauthor of a book, Presenting Medical Statistics from Proposal to Publication, covering analysis and data visualization. In addition, he has authored and coauthored more than a hundred peer-reviewed publications and refereed presentations in topics ranging from phonetics to obstetrics, dyspepsia to dyslexia, and health disparity to brachytherapy. His recent work includes the development and patenting of the analytics behind SCAN360, a web portal that describes cancer rates and disease risk factors for all of Florida. Currently, he is developing tools to monitor rates of substance use disorder for 16 communities in New York and using machine learning methods to model patterns of substance abuse in people seeking care for addiction to opioids. Additionally, he is working on several projects at the intersection of mental health and HIV. Field of Interest: Data Science & Biostatistics Curriculum Vitae Research Publications

University of Miami Miller School of Medicine Department of Public Health Sciences

Yuguang (James) Ban, Ph.D., is a Research Assistant Professor of Biostatistics in the Department of Public Health Sciences and Biostatistics and Bioinformatics Shared Resource of the Sylvester Comprehensive Cancer Center. He has collaborated with many cancer genomic researchers at Sylvester since he joined the University of Miami in 2015, and held a role as bioinformatics project manager for BBSR since 2018. Previously, he has been trained as a postdoctoral fellow in the Department of Statistics at Northwestern University, where he developed an innovative machine learning method for analyzing microbial network generated from high-dimensional metagenomic data. His research focus is on metagenomic data analysis as well as integration of multiple types of next generation sequencing data. For example, recently, he has been collaborating with Dr. Abreu from the Department of Medicine on a diet study where he leveraged nutrient, microbiome, and metabolite data to understand how diet impacts on IBD patients. In addition, he has extensive experience in developing statistical methods and tools for pathway analysis, and conducting genomic data analysis for various types of omics data. Field of Interest: Computational Statistics and Bioinformatics in Genomics Curriculum Vitae Research Publications John C. Beier, Sc.D., is a Professor and Director of the Division of Environment and Public Health in DPHS at UMMSM. Dr. Beier’s research career is committed to the ecology and control of vector-borne diseases, including malaria, dengue, Zika, other arboviruses, and leishmaniasis. With a strong network of international collaborators and University of Miami faculty and students from several departments and centers, interdisciplinary research is being conducted on vector species of mosquitoes and sand flies, pathogen transmission 28

dynamics, determinants of human risk, novel vector control methods, and innovative integrated vector management strategies for disease control. He has 300 publications. Dr. Beier’s current research is supported by two NIH grants that involve studies on malaria epidemiology and control in Latin America, and the ecology and behavior of African malaria vectors, and a CDC grant for vector-borne diseases in southeastern U.S. He is also involved with research on new approaches for malaria and dengue vector control. He was ranked by BiomedExperts #1 for Anopheles mosquitoes and #2 for Disease Vectors. Dr. Beier teaches Ecology and Control of Vector-Borne Diseases, and in 2013 won the Best Teacher award. In external activities, he is an Editor for Acta Tropica, a past member of the World Health Organization Vector Control Advisory Group, past Chairman of review committee for the Department of Defense Military Infectious Disease Research program for Vector Biology, and past Chairman of the National Institutes of Health study panel on Vector Biology. Field of Interest: Vector Biology & Control Curriculum Vitae Research Publications Scott C. Brown, Ph.D., is an Associate Research Professor in DPHS at UMMSM. He has a secondary appointment in the University of Miami School of Architecture. Previously, he completed postdoctoral fellowships in cognitive aging and behavioral he developed. His main area of research is on neighborhood built (physical) and social environments and public health. Dr. Brown is currently the UM Site PI of a CDC-funded project on promoting physical activity opportunities through Miami-Dade Parks, funded by the CDC’s Partnerships to Improve Community Health (PICH), in partnership with the Florida Department of Health at Miami-Dade, and MiamiDade Parks, Recreation and Open Spaces (MDPROS). He is also an investigator on another CDC-funded project led by University of Florida researchers examining built and social environmental risk and protective factors for Zika and other mosquito-borne illnesses. Dr. Brown was recently Principal Investigator (with Professor Elizabeth Plater-Zyberk, in the School of Architecture) of a HUD-funded research study examining the relationship of built-environment “walkability” characteristics (e.g., land-use University of Miami Miller School of Medicine Department of Public Health Sciences

mix; parks; greenery; transit) to health-outcomes and healthcare costs among Medicare/Medicaid beneficiaries in MiamiDade County, Florida. He was also recently an Investigator on an NIH-funded study examining the relationship of the built environment to Hispanic elders' social behaviors and their cognitive, affective, and physical functioning. Other research examines the relationship of the health-care built environment to patients' health outcomes; the role of the built environment in children’s conduct problems; and the role of accreditation of echocardiographic testing facilities utilized by Medicare beneficiaries nationally. In summary, Dr. Brown has a general interest in the impacts of neighborhood physical and social environments on residents’ health and well-being across their life span. Field of Interest: Built Environment, Behavior & Health Curriculum Vitae Research Publications Eric C. Brown, Ph.D., is an Associate Professor at UMMSM’s DPHS’ Division of Prevention Science and Community Health, where he directs the Implementation Science track for DPHS’s Ph.D. Program. Dr. Brown works on the development, implementation, and testing of community- and school-based preventive interventions in the United States and in Latin America. He is the Principal Investigator of a U.S. National Institute on Drug Abuse-funded study examining risk factors for adolescent drug use among the United States, Colombia, Chile, and Brazil; and is a former Investigator on the Community Youth Development Study’s communityrandomized controlled trial of the Communities That Care (CTC) prevention system. Dr. Brown also is a former CoPrincipal Investigator on the adaption and implementation of the CTC prevention system in Chile (called Comunidades Que Se Cuidan, in Spanish), and has consulted on the adaptation and implementation of Comunidades Que Se Cuidan in Colombia. Prior to coming to the UM, Dr. Brown was a faculty member with the Social Development Research Group (SDRG) at the University of Washington’s School of Social Work. At the SDRG, Dr. Brown was the Principal Investigator of a schoolrandomized controlled trial of Steps to Respect: A Bullying Prevention Program and a Co-Investigator of the Bill and Melinda 29

FACULTY BIOGRAPHIES CONTINUED Gates Foundation-funded Supporting Early Adult Transition Study, a developmental evaluation of the Jim Casey Youth Opportunities Initiative. Other research projects that Dr. Brown worked on include the Multisite Evaluation of Second Step: Student Success through Prevention of Bullying and Sexual Harassment, the International Youth Development Study, Preventing Adolescent Cannabis Use in the Netherlands and the United States--A Bi-national Investigation of the Communities That Care Prevention System, the Raising Healthy Children Project, and the National Adolescent Treatment Study. Dr. Brown’s research interests center around the application of advanced research methods to evaluate the effectiveness of prevention programs and implementation systems. He currently teaches Implementation Science, Disease Prevention and Health Promotion, and Advanced Quantitative Research Methods in Prevention Science. He is a member of the Society for Prevention Research International Committee and was the recipient of the 2013 International Collaboration Award from the Society for Prevention Research. Field of Interest: Community-Based & International Prevention Science Curriculum Vitae Research Publications

Alberto Caban-Martinez, Ph.D., DO, MPH, is a board-certified osteopathic physician and epidemiologist, and an Associate Professor of Public Health Sciences in the Division of Environment and Public Health of the UMMSM's DPHS. He is the Director of the Musculoskeletal Disorders and Occupational Health Lab and Associate Director of the Miami Occupational Research Group (MORG). His primary program of research concerns the prevention of musculoskeletal disorders among U.S. workers. He is the principal investigator of the NIOSH-funded Musculoskeletal Study of Construction Workers’ Longitudinal Exposures (MUSCLE) that follows a cohort of 500 commercial construction workers using a longitudinal study design with repeated measurements to better understand the occurrence and course of multisite musculoskeletal acute and chronic pain and its severity, as well as its association to occupational and non-occupational risk factors. He is also co-leading the Home Health Occupations - Musculoskeletal Examinations (HHOME), a mixed methods pilot research study examining the musculoskeletal disorders in minority home health workers (i.e., home health aides, personal care attendants, homemakers, etc.) with the primary goal of understanding occupational factors that can reduce overexertion and physical demands in their work environment. He most recently completed data collection of a NIAMSfunded mixed-methods study to develop and validate an ergonomics and fatigue survey instrument for commercial construction workers. He is a standing member of the NIOSH National Occupational Research Agenda (NORA) Construction Sector and Mining Sector Council as well as a member of the National Board of Public Health Examiners, Item Writing Committee. When he is not in the research office, Dr. CabanMartinez is an avid outdoor runner, exploring the South Florida running paths. Field of Interest: Occupational Health & Safety Curriculum Vitae Research Publications

University of Miami Miller School of Medicine Department of Public Health Sciences

Adam Carrico, Ph.D., is a Professor of Public Health Sciences and Psychology and Director of the Division of Prevention Science and Community Health. Dr. Carrico’s clinical and translational research program targets the intertwining epidemics of substance use and HIV/AIDS. His clinical research focuses on boosting the effectiveness of motivational enhancement interventions, such as contingency management and motivational interviewing for HIV/AIDS prevention with people who use stimulants such as methamphetamine. His translational research in neuroimmune pharmacology examines the bio-behavioral pathways whereby substance use may amplify risk for HIV acquisition and clinical HIV progression. Most recently, his team is also preparing to launch one of the first cohort studies to examine the bio-behavioral pathways whereby methamphetamine and HIV could increase the risk of infection with the novel coronavirus. Dr. Carrico’s research program provides an ideal platform to mentor the next generation of clinical and translational researchers in HIV/AIDS prevention. He has served as the primary mentor for two predoctoral fellows, four postdoctoral fellows, and three junior faculty. Many of his former trainees received funding from the National Institute on Drug Abuse to support their research and training. Field of Interest: HIV/AIDS Research Curriculum Vitae Research Publications Xi (Steven) Chen, Ph.D., is a Professor of Biostatistics in DPHS at UMMSM. He is also the Director of the Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center. Previously, he was a tenured Associate Professor at Vanderbilt University School of Medicine. Dr. Chen’s research interests focus on statistical genomics for cancer research, especially developing and applying innovative statistical and bioinformatics methodology to facilitate translational genomic University of Miami Miller School of Medicine Department of Public Health Sciences

research from bench to clinic. Dr. Chen is the Principle Investigator of a NCI R01 grant “Integrative prediction models for metastasis risk in colon cancer” which collects data on mRNA expression, somatic mutations, and clinical information to develop clinical-genomic risk prediction models and to identify subtypes for colon cancer patients. Dr. Chen is also a major contributor for identifying six triple-negative breast cancer (TNBC) subtypes and corresponding gene signatures. He is the developer of the web-based software “TNBCtype”, which has been widely used by the breast cancer research community. Field of Interest: Statistical Genomics, Biomarker Discovery & Prediction Modeling Curriculum Vitae Research Publications Daniel Andrés Díaz-Pachón, Ph.D., is a Research Assistant Professor in the Division of Biostatistics in DPHS at UMMSM. His research, current and former, can be divided in four areas: probability, information theory, machine learning, and theoretical statistics. In probability, he is working on population genetics. Particularly, his current interest is on the Spatial Lambda-Fleming-Viot process (SLFV) to model evolution in the spatial continuum, developed by Alison Etheridge and collaborators. Surprisingly enough, his current work relies heavily on the research for his doctoral dissertation, which was entirely focused on continuum percolation and large deviations of stable allocations. In information theory, he is working on active information, based on Bernoulli’s Principle of Insufficient Reason. In this endeavor, he is collaborating with engineer Robert Marks II, who developed the concept with his collaborators for uniform distributions. Dr. DíazPachón’s project is on the generalization of the concept to more general distributions. In machine learning, he has currently begun to work with Dr. Sunil Rao and Dr. Hemant Ishwaran on the problem of learnability, which depends on a concept called stability. Part of the interest is to analyze, and hopefully improve, existing inequalities. In the past, as part of his postdoctoral research and together with Dr. Sunil Rao and Dr. Jean-Eudes Dazard, he was able to transform a supervised bump-hunting algorithm into a more efficient unsupervised one, when the sample is large. In theoretical statistics, together with Dr.’s Sunil Rao and Jean-Eudes Dazard, he is working to understand when in learning settings, mainly 31

FACULTY BIOGRAPHIES CONTINUED regression, the rotation (not the projection of the space) to principal components of the explanatory variables makes sense to explain the response. Field of Interest: Theoretical Statistics & Population Genetics Curriculum Vitae Research Publications Daniel J. Feaster, Ph.D., is a Professor in DPHS at UMMSM. Dr. Feaster has over 25 years of experience in the design, implementation, and analysis of large longitudinal studies, including clinical trials of HIV-positive and drug-abusing populations, as well as both individual and family-focused preventive and treatment interventions. He has been the statistician on numerous federally funded projects, including center grants, RO1s, cooperative agreements, and multi-site trials. Dr. Feaster has expertise in multi-level (also known as hierarchical linear) modeling, structural equation modeling and extensive experience with longitudinal analysis and methods for handling missing data. He has been the statistician on numerous federally funded projects, including center grants, RO1s, cooperative agreements, and multi-site trials. Dr. Feaster has expertise in multi-level (also known as hierarchical linear) modeling, structural equation modeling and extensive experience with longitudinal analysis and methods for handling missing data. Field of Interest: Hierarchical Linear, Structural Equation Modeling & Longitudinal Analysis Curriculum Vitae Research Publications Julio Frenk, MD, Ph.D., MPH, a noted leader in global health and a renowned scholar became the sixth President and a Professor in DPHS at UM on August 16, 2015.

University of Miami Miller School of Medicine Department of Public Health Sciences

Prior to joining the University of Miami, Dr. Frenk was Dean of the Faculty at the Harvard T.H. Chan School of Public Health since January 2009. While at Harvard, he was also the T & G Angelopoulos Professor of Public Health and International Development, a joint appointment with the Harvard Kennedy School of Government. Dr. Frenk served as the Minister of Health of Mexico from 2000 to 2006. There he pursued an ambitious agenda to reform the nation’s health system and introduced a program of comprehensive universal coverage, known as Seguro Popular, which expanded access to health care for more than 55 million previously uninsured Mexicans. Dr. Frenk was also the founding director-general of the National Institute of Public Health in Mexico, one of the leading institutions of its kind in the developing world. In 1998, he joined the World Health Organization (WHO) as executive director in charge of Evidence and Information for Policy, WHO’s first-ever unit explicitly charged with developing a scientific foundation for health policy to achieve better outcomes. Other professional accomplishments include serving as a senior fellow in the global health program of the Bill & Melinda Gates Foundation, as president of the Carso Health Institute in Mexico City, founding chair of the board of the Institute for Health Metrics and Evaluation at the University of Washington, and co-chair of the Commission on the Education of Health Professionals for the 21st Century, which published its influential report in the leading journal The Lancet in 2010, triggering a large number of follow-up initiatives throughout the world. Dr. Frenk holds a medical degree from the National University of Mexico, as well as a master of public health and a joint Ph.D. in Medical Care Organization and in Sociology from the University of Michigan. He has been awarded honorary doctorates from several institutions of higher learning. In September of 2008, Dr. Frenk received the Clinton Global Citizen Award for changing “the way practitioners and policy makers across the world think about health.” In 2016, he received the Welch-Rose Award for Distinguished Service to Academic Public Health from the Association of Schools and Programs in Public Health. Dr. Frenk is a member of the U.S. National Academy of Medicine, the American Academy of Arts and Sciences, and the National Academy of Medicine of Mexico, and is on the board of the United Nations Foundation. foundation for health policy to achieve better outcomes. Other professional accomplishments include serving as a senior fellow in the global health program of the Bill & Melinda Gates Foundation, as president of the Carso Health Institute 32

in Mexico City, founding chair of the board of the Institute for Health Metrics and Evaluation at the University of Washington, and co-chair of the Commission on the Education of Health Professionals for the 21st Century, which published its influential report in the leading journal The Lancet in 2010, triggering a large number of follow-up initiatives throughout the world. Dr. Frenk holds a medical degree from the National University of Mexico, as well as a master of public health and a joint Ph.D. in Medical Care Organization and in Sociology from the University of Michigan. He has been awarded honorary doctorates from several institutions of higher learning. In September of 2008, Dr. Frenk received the Clinton Global Citizen Award for changing “the way practitioners and policy makers across the world think about health.” In 2016, he received the Welch-Rose Award for Distinguished Service to Academic Public Health from the Association of Schools and Programs in Public Health. Dr. Frenk is a member of the U.S. National Academy of Medicine, the American Academy of Arts and Sciences, and the National Academy of Medicine of Mexico, and is on the board of the United Nations Foundation.

funded studies focused on HIV-prevention and care. Her current work focuses on HIV-related syndemics, resilience, and PrEP among sexual minority men. Dr. Harkness is also starting a new study that will identify barriers and facilitators to Latino men who have sex with men’s engagement in HIV-prevention and behavioral health services. In her future work, Dr. Harkness plans to conduct community-based research with implications for interventions to reduce SGM health disparities. Field of Interest: Optimizing Mental & Physical Health for Sexual & Gender Minority Curriculum Vitae Research Publications

Field of Interest: Health Care Reform & Universal Coverage Curriculum Vitae Research Publications Audrey Harkness, Ph.D., is a clinical psychologist and a Research Assistant Professor of Prevention in DPHS at the UMMSM. Dr. Harkness’ work focuses on optimizing mental and physical health for sexual and gender minority (SGM) communities with a focus on HIV-prevention. Prior to her graduate training, Dr. Harkness worked in HIV-prevention and SGM health at the University of California, San Francisco AIDS Health Project and the San Francisco Department of Public Health AIDS Office. Dr. Harkness completed her Ph.D. in Counseling, Clinical, and School Psychology at the University of California, Santa Barbara, where her work focused on understanding and improving SGM mental health. She is now a postdoctoral fellow in the HPAC Lab at UM, where she is a collaborator, coordinator, clinical supervisor, and interventionist on several

University of Miami Miller School of Medicine Department of Public Health Sciences

FACULTY BIOGRAPHIES CONTINUED WayWay Hlaing, MBBS, MS, Ph.D., FACE, is an epidemiologist and a professor (Educator) in DPHS at UMMSM. She is also the Director of the Ph.D. in Epidemiology program in DPHS.

of the American College of Epidemiology (FACE). Field of Interest: Chronic Conditions & Health Disparities Curriculum Vitae Research Publications Viviana E. Horigian, MD, MHA, is a Professor, Educator, in DPHS at the UMMSM. She is currently serving as the Director of Public Health Education and as a director of the Americas Initiative for Public Health Innovation.

Previously, she held a tenured faculty position in the Department of Epidemiology and Biostatistics in Stempel School of Public Health at Florida International University. She practiced as a physician before pursuing her graduate degrees in Health Sciences and Epidemiology. Dr. Hlaing’s teaching career began during her graduate studies in early 1990s. She was a recipient of two prestigious awards at FIU: Faculty Senate’s Excellence in graduate studies in early 1990s. She was a recipient of two prestigious awards at FIU: Faculty Senate’s Excellence in Graduate Teaching Award and Stempel Public Health Association (SPHA)’s Faculty Advisor Award. She received Graduate School’s Outstanding Graduate Program Director Award at UM in 2016 and was a recipient of Delta Omega Honorary Society for studies in Public Health’s Excellence in Teaching Award twice in 2018 and 2020. She currently teaches core and elective epidemiology courses in the Master’s, Ph.D., MD/MPH and MD/PhD programs in DPHS at UM: Fundamentals of Epidemiology, Advanced Epidemiologic Methods I and II, Ethics in Epidemiology, and Chronic Disease Epidemiology. Dr. Hlaing’s current research interests focus on the areas of obesity and cardiovascular disease epidemiology and health disparities. Her education research focuses on the doctoral level competencies in epidemiology and ethics in epidemiology. She serves on several DPHS committees: Admission, Curriculum, and Graduate Executive Program Committees.

Dr. Horigian is also an Executive Director of the Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network (CTN) housed at the University of Miami. The Florida Node Alliance is a partnership between scientists and program leaders at the University of Miami with scientists and practice leaders from community treatment agencies located in Florida, Colorado, North Carolina, Georgia, Massachusetts, Puerto Rico, and the Virgin Islands. As partners, scientists and practitioners design, implement, and train in interventions for alcohol and drug abuse treatment.

In external activities, she served on the National Board of Public Health Examiners (NBPHE) for the epidemiology section of the Certified in Public Health (CPH) exam and as the research reviewer for various epidemiology organizations including the Epidemiology Congress of North America and the International Epidemiological Association’s World Congress of Epidemiology. She serves on the Ethics Committee of the American College of Epidemiology (ACE), the Educational Committee of the Society for Epidemiologic Research (SER) and Ethics Section of the American Public Health Association (APHA). She is on the PhD Council of the Association of Schools and Programs in Public Health (ASPPH) and is a fellow

Dr. Horigian’s research career has been committed to improving practice through the implementation of clinical trials in real-world settings, and more recently in creating the local capacities that would allow the implementation of such trials. She was the Principal Investigator of a technology transfer project that aimed to develop the research infrastructure for the implementation of rigorous randomized clinical trials in Mexico. In this role, she mentored investigators from the National Institute of Psychiatry in Mexico on the design, implementation, safety, and interpretation of the results of RCTs in real-world treatment settings.

University of Miami Miller School of Medicine Department of Public Health Sciences

Dr. Horigian has contributed to the design and implementation of the trials led by the Florida Node Alliance, manages its day to day operations, and has more than 15 years of experience in the implementation of multisite randomized clinical trials. Most of her research within the CTN network has been dedicated to evaluating the effects of a family therapy intervention, Brief Strategic Family Therapy BSFT®, for adolescent drug abuse.

Due to her work, she received recognition from the National Institutes of Psychiatry in Mexico for her and the Florida Node Alliance's contributions on the establishment of a Mexican Clinical Trials Network. She has used the same methodology for technology transfer to developing research capacity in Ecuador and Chile. Due to her international leadership, she was honored with the 2015 National Institute on Drug Abuse (NIDA) International Program Award of Excellence. She is a member of the Society of Clinical Trials and the National Hispanic Science Network. Field of Interest: Research Design & Implementation of Treatments for Drug Abuse, MPH & MSPH Programs Curriculum Vitae Research Publications Jennifer Hu, Ph.D., is a Professor in DPHS, Biochemistry and Molecular Biology, and Human Genetics and Genomics at the UM. As a trans-disciplinary cancer researcher, she has training in basic sciences (Ph.D. in Biochemistry and Molecular Biology) and cancer (M.S. in Biostatistics and Epidemiology) and her research mainly focuses on the molecular and genetic mechanisms of breast cancer risk and survival disparities and implication of DNA damage and repair in precision medicine. The pioneer research from her laboratory and collaborative effort that has significant impact on cancer research field include: (1) deficient DNA repair and elevated DNA damage in human breast and prostate cancer risk; (2) racial/ethnic-specific polygenic models of DNA repair in human cancer risk and tumor TP53 mutations; (3) functional implication of DNA repair genotypes in human cancer risk and targeted therapies; (4) gene-diet interactions in human colon and breast cancer risk; and (5) genome wide association studies of novel breast cancer and ER-negative breast cancer susceptibility loci in women of African ancestry.

University of Miami Miller School of Medicine Department of Public Health Sciences

She is the course director for Molecular and Genetic Epidemiology and Cancer Epidemiology and Prevention. Her research program has been continuously funded for more than 20 years with peer-reviewed grants from NIH/NCI/ACS/DOD/ FL since 1992. Her broad scientific expertise includes basic laboratory research in DNA damage/repair, molecular and genetic epidemiology, genomic prediction models of survival, precision medicine, and cancer health disparities. With her diverse research background and a strong commitment to training/education, she has successfully mentored a number of young scientists with outstanding career development. She has served on more than 50 NIH/NCI/DOD study sections; became a regular member of the NCI subcommittee F for training grants in 2013 and the chair of the DOD prostate cancer research study section since 2011. Dr. Jennifer Hu has served in several NIH study sections and the Congressional Directed Medical Research Program (CDMRP)-breast cancer and prostate cancer programs. Field of Interest: Cancer Center & Control Curriculum Vitae Research Publications Hemant Ishwaran, Ph.D., is a Professor in DPHS and is the Director of Statistical Methodology and the Director of Graduate Studies in the Division of Biostatistics at UMMSM. Dr. Ishwaran is also affiliated with the Sylvester Comprehensive Cancer Center (SCCC) and the Center for Computational Sciences (CCS). Dr. Ishwaran’s research involves machine learning methods and he has pioneered open source software for random forests, an ensemble tree-based technology. Dr. Ishwaran has worked with the American Joint Committee on Cancer (AJCC) using random forests to develop a data driven stage grouping for esophageal cancer patients for the 7th edition of the AJCC Cancer Staging Manual. Dr. Ishwaran is the Joint-Editor for the Sankhya A and B series journal.

FACULTY BIOGRAPHIES CONTINUED Field of Interest: Developing Machine Learning Methods Curriculum Vitae Research Publications Mariano Kanamori, Ph.D., is an epidemiologist committed to reducing health disparities in underserved communities. He has over twenty-six years of experience applying qualitative and quantitative methodologies to global health issues. Dr. Kanamori’s community based participatory research (CBPR) studies using advanced social network analysis have focused on substance use disorders and HIV among underserved communities in Latin America, sub-Saharan Africa and the U.S. Dr. Kanamori’s research and initiatives have operated under the auspices of of The National Institutes of Health, USAID-PEPFAR, The European Union, UNICEF, Peru Health Ministry, Family Planning Management/John Snow, The Population Council, Salesian Missions-Ethiopia, Maryland Department of Health, and Asociación Benéfica Prisma Dr. Kanamori has published 24 scientific papers in peer-reviewed journals and co-authored a chapter in Health Issues in Latino Males: A Social and Structural Approach (2008, Rutgers University Press), which focused on Latino males’ health status in the U.S. He has presented his work in 48 national and international conferences and talks. Dr. Kanamori is an Assistant Professor at UMMSM Division of Prevention Science and Community Health. At UM, he also leads the PROGRESO (Programa de Redes Sociales) Lab where he is implementing two NIH funded projects. The first study (R00), funded by NIDA, implements innovative and advanced social network modeling using dyadic, egocentric, twomode network, spatial, and multilevel mediation analyses to understand how Latino cultural values and acculturation stress impact social network configurations and dynamics that could then act as protective or risk factors for substance use disorders and HIV risk in the Latino seasonal farmworker community. The second study called PrEParados, funded by the CFARADELANTE Program, studies two social networks (friendship socio-centric networks and sexual egocentric networks) of Latino men who have sex with men (LMSM) living in MiamiDade County, Florida. The aim of this study is to understand how PrEP programs can harness the potential of social University of Miami Miller School of Medicine Department of Public Health Sciences

networks and venue-based affiliations to facilitate LMSM’s progress in the PrEP cascade. Dr. Kanamori teaches the course EPH 647 CBPR - Community Based Participatory Research. This course is designed to provide students with a robust and comprehensive theoretical and practical foundation in CBPR. While the majority of this course focuses on traditional CBPR methodology for geographically bound communities, theoretical lectures have been designed to be cutting edge by including virtual communities. Dr. Kanamori has advanced HIV and substance use disorder implementation in the first social network study which analyzes how the opioid epidemic is evolving in the Latino community. The second phase of this study is one of three proposals: The University of Miami has selected for submission to NIH for the “Ending the HIV Epidemic: A Plan for America” initiative. Field of Interest: Latinos, Substance Use Disorders & HIV Studies Curriculum Vitae Research Publications An internationally renowned health economist and expert in Latin American health systems and social sectors, Felicia Knaul, Ph.D., is a Professor in DPHS at UMMSM and has secondary appointments in the Department of International Studies and the Department of Anthropology in the College of Arts & Sciences, the Department of Health Sector Management and Policy in the School of Business Administration, and the Division of Population Health and Computational Medicine in the Department of Medicine. Dr. Knaul’s research focuses on global health, cancer and breast cancer in low- and middle-income countries, women and health, health systems and reform, health financing, access to pain control and palliative care, poverty and inequity, gender equity and female labor force participation, and children in especially difficult circumstances. Prior to coming to Miami, Dr. Knaul served as Director of the Harvard Global Equity Initiative and Associate Professor at the Harvard Medical School. She has held senior government posts in Mexico and 36

Colombia and worked for bilateral and multilateral agencies including the World Health Organization, the World Bank, and UNICEF. She maintains a research base in Mexico anchored at the Mexican Health Foundation and the National Institute of Public Health of Mexico. She has produced over 170 academic and policy publications, including several papers on Mexico and health reform in The Lancet where she also recently coauthored the Commission Report on Women and Health. She is currently Chair of the Lancet Commission on Global Access to Palliative Care and Pain Control. Dr. Knaul works as both a researcher and advocate on cancer globally. After she was diagnosed with breast cancer in 2007, Dr. Knaul founded the Mexican non-profit organization, Cáncer de Mama: Tómatelo a Pecho, which undertakes and promotes research, advocacy, awareness, and early detection initiatives for breast cancer throughout Latin America. Her journey is documented in her book Beauty without the Breast, and has been featured in The Lancet, Science and Cancer Today. Her program of research on breast cancer and health systems. Field of Interest: Cancer Research & Policy Development Curriculum Vitae Research Publications Tulay Koru-Sengul, Ph.D., is a Research Associate Professor in DPHS at UMMSM. She is a member in the Cancer Epidemiology and Prevention Program, Clinical Protocol Review Committee, the Data and Safety Monitoring Committee and a faculty biostatistician in the Biostatistics and Bioinformatics Core at Sylvester Comprehensive Cancer Center. She earned her Master’s degree in biostatistics from Johns Hopkins University, and both Master’s and Doctoral degrees in statistics from University of Pittsburgh. She held research positions at University of Pittsburgh and faculty appointments at the State University of New York at Buffalo, University of Saskatchewan and McMaster University in Canada. Along with her faculty appointments, she was the Director of the Statistical Consulting Laboratory in the Department of Biostatistics at the State University of New York at Buffalo, a Research Scientist at Saskatchewan Health Quality Council, and a faculty biostatistician in the Clinical Trials Methodology Group University of Miami Miller School of Medicine Department of Public Health Sciences

at Ontario Clinical Oncology Group in Canada. Her research interests include development and application of statistical methods for biological responses that vary in time and occasion, design and analysis of clinical trials, missing data analysis, and statistical methods for high dimensional medical data. Her current cancer research interests focus on the areas of health disparities in cancer diagnosis, prevention, screening, survival and other outcomes using large population-based databases. She currently teaches Medical Biostatistics in the MPH, MD/MPH programs and actively mentors several graduate students, medical residents and fellows. Field of Interest: Statistical Methods for Biological Responses Curriculum Vitae Research Publications Naresh Kumar, Ph.D., is a Professor of Environmental Health in DPHS, Abess Center for Ecosystem Science and Policy, and Department of Geography and Regional Studies at the University of Miami. Dr. Kumar’s research and teaching are dedicated to prevent and manage environmental disease burden. A novel aspect of his research includes engaging communities in prevention measures through a personalized real-time environmental risk surveillance system. This system monitors and records environmental pollution in real-time and informs targeted users (such as asthmatic and COPD patients) about hazardous concentrations in real-time through cellphones and web. Dr. Kumar is the Co-PI of an EPA grant that aims to develop and validate novel methods of quantifying ambient air pollution at any given location and time by integrating satellite remote sensing and chemical transport models. He is the Co-PI of an NSF grant that has developed a cost-effective spatial sampling and survey methodology to screen populations for demographic and health characteristics. His research on air pollution and health has been featured in high profile media, such as Science Daily and Wall Street Journal. He currently teaches “Environmental Health” and “Methods of Environmental Epidemiology” in MD/MPH, MPH and Ph.D. programs. He serves as a reviewer for NIH and NSF, and other high impact journals, such as Environment Science and Technology, Environmental Health Perspective and Public Opinion Research. Dr. Kumar’s current research 37

FACULTY BIOGRAPHIES CONTINUED focuses on real-time personalized health risk surveillance, novel spatiotemporal methodologies that compute environmental disease burden, and on the quantification of meteorological conditions that mediate the health effects of air pollution. Other focuses include assessing the burden of disease and disability in response to extreme weather, including hurricanes. He also is the Director of the first Master of Science in Climate and Health graduate program in the nation. Every year, Dr. Kumar leads a climate and health symposium that brings different stakeholders to address health effects of climate and extreme weather. Field of Interest: Environmental Health Risk Surveillance Curriculum Vitae Research Publications Deukwoo Kwon, Ph.D., is a Research Assistant Professor in Biostatistics and Bioinformatics Shared Resource (BBSR) in DPHS and the Sylvester Comprehensive Cancer Center at UMMSM. He earned his Master’s degree in statistics and Ph.D. in statistics from Texas A&M University and worked at the National Cancer Institute for six years. Dr. Kwon worked on various epidemiologic studies including radiation exposure assessment, uncertainty analysis, and measurement error models in dose-response relationship at NCI. He joined Sylvester BBSR in October 2011. He has extensive experience conducting statistical analysis for various areas: statistical methods applied to clinical trials and epidemiologic studies related to cancer, novel approaches to statistical design and analysis of phase I and phase II clinical trials, survival analysis, longitudinal data analysis, Bayesian inference, and highdimensional data analysis. He is a member of Protocol Review and Monitoring Committee at Sylvester Comprehensive Cancer Center. Field of Interest: Bayesian Inference, Clinical Trial Design & High-Dimensional Data Analysis Curriculum Vitae Research Publications University of Miami Miller School of Medicine Department of Public Health Sciences

David Lee, Ph.D., has been a faculty member in DPHS at UMMSM since 1990. He serves as Department Chair, and oversees all graduate programs on Miller School campus. Dr. Lee is a chronic disease and occupational epidemiologist and has been continuously funded as Principal/Co-Principal Investigator on various grants from the National Institutes of Health and the Centers for Disease Control and Prevention since 1993. He also serves as Principal Investigator for the Florida Cancer Data System, which is the second largest state cancer registry in the United States. Dr. Lee is lead or co-author on over 250 peer-reviewed research articles. Additionally, students are active members of his research teams contributing to 50+ student-led publications in leading public health and biomedical journals. A strong emphasis on health disparity reduction is a crosscutting theme within his research portfolio. Dr. Lee’s current research interests include: public health applications of mind-body practices for the prevention and management of stress and living with chronic disease, enhancing the health of the US workforce, cancer surveillance and prevention, and sensory impairment surveillance. Field of Interest: Occupational & Chronic Disease Epidemiology, Accreditation & Program Governance Curriculum Vitae Research Publications Howard Liddle, Ed.D., is a Professor in DPHS and Director of the Center for Treatment Research on Adolescent Drug Abuse at UMMSM. As a psychologist, Dr. Liddle’s research focus is on the development, testing, implementation and dissemination of family based treatment for adolescent substance abuse and

and delinquency. His research in this area has been funded by a variety of NIDA grants since 1985. Multidimensional Family Therapy (MDFT) is the most researched family-based treatment in the adolescent substance abuse specialty, and MDFT studies and the clinical model are recognized nationally and internationally. MDFT has been implemented and sustained in 100+ communities around the U.S. and in eight European countries. Recent and current projects include implementation grants that test the incorporation of a cross system juvenile justice -- substance abuse and HIV prevention intervention in the Connecticut state justice system, and a controlled trial testing MDFT in a juvenile justice day treatment school setting. Dr. Liddle’s work has been recognized with career research awards from the American Association for Marriage and Family Therapy, the American Family Therapy Association, the Hazelden Foundation, and the American Psychological Association. The MDFT approach is practiced in clinics around the United States. As a result of a successful, multisite, multinational controlled trial of MDFT in five European countries, MDFT is now practiced in these and other European nations. Field of Interest: Adolescent Substance Abuse Curriculum Vitae Research Publications Min Lu, Ph.D., is a Research Assistant Professor of Biostatistics in DPHS at UMMSM. She received her Doctoral degree in Biostatistics from the University of Miami in 2018. Her current work is centered around developing and integrating machine learning approaches to detect the causal relationship between treatments and outcome and facilitate personalized treatment decision. She has developed several statistical models with her advisor, Dr. Hemant Ishwaran, for estimating individual treatment effects and obtaining individualized treatment rules that can accommodate continuous, binary, or survival outcomes. She also works on statistical inferences of Random Forest Variable Importance, which permit clinicians to connect informative features to patient outcomes and treatment effects. For example, she University of Miami Miller School of Medicine Department of Public Health Sciences

Random Forest Variable Importance, which permit clinicians to connect informative features to patient outcomes and treatment effects. For example, she applied her methodological framework to ischemic cardiomyopathy and esophageal cancer with Dr. Ishwaran and surgeons from the Cleveland Clinic, with the purpose of facilitating precision therapy using observational dataset that identifies the specific treatment predicted to maximize survival for a patient. Field of Interest: Machine Learning, Causal Inference & Variable Selection Curriculum Vitae Research Publications Kathryn E. McCollister, Ph.D., is a Professor and Health Economist and is the Director of the Division of Health Services Research and Policy in DPHS at UMMSM. Dr. McCollister’s primary research focuses on economic evaluation (cost-effectiveness treatment and benefit-cost analyses) of treatment interventions for individuals with substance use disorders, including criminal offenders and pregnant/parenting women. She has also conducted economic studies of a family-based HIV and drug use preventive intervention for Hispanic youth, an early childcare center obesity prevention program, and schoolbased primary care health centers among disadvantaged communities in Miami-Dade County. Dr. McCollister’s secondary area of research involves estimating the burden of disease and disparities in health-related quality of life among occupational groups and the visually impaired. Dr. McCollister has served as the Principal Investigator on projects funded by the National Institutes of Health (NIH) and the Robert Wood Johnson Foundation. She has also collaborated on numerous projects funded by the NIH, Substance Abuse and Mental Health Services Administration, Office of Juvenile Justice and Delinquency Prevention, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, and the State of Florida. Dr. McCollister is currently the Co-Director of the Methodology Core of the NIDA-funded Center for Health Economics 39

FACULTY BIOGRAPHIES CONTINUED of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH), led by colleagues at Weill Cornell Medical College. In addition to conducting research, Dr. McCollister teaches Health Economics in the MPH and MD/MPH programs in DPHS. She also serves as a grant peer reviewer for the NIH and as an editorial board member for the Journal of Substance Abuse Treatment. Dr. McCollister is a leading expert in the health economics of treatment strategies for substance use disorders, and one of the lead economists on the multistate, National Institute on Drug Abuse-funded Helping End Addiction Long-term (HEALing) Communities initiative to implement and test evidence-based practices for reducing fatal opioid overdoses and related consequences of the national opioid epidemic. Dr. McCollister developed estimates of the societal cost of crime for 13 unique criminal offenses that have been incorporated into national data sets (Global Appraisal of Individual Needs) and applied in numerous studies to calculate reduced social and criminal justice system costs of interventions for substance use disorders and crime prevention programs. Additionally, she contributed to the development and application of standardized costing surveys based on the Drug Abuse Treatment Cost Analysis Program (DATCAP) to capture patient and family/caregiver costs attributable to self- or family-member participation in substance use disorder treatment. Dr. McCollister was also one of the lead investigators on the cost-effectiveness analysis of the first U.S.-based, multi-site, randomized comparative effectiveness trial of pharmacotherapy for opioid use disorders, extended-release naltrexone (Vivitrol versus buprenorphine-naloxone (Suboxone). Field of Interest: Economic Evaluation of Evidence-Based Interventions Curriculum Vitae Research Publications

Shari Messinger, Ph.D., is a Professor in the Division of Biostatistics and Director of Biostatistics Collaboration and Consulting Core. She additionally serves as Director of the Research Design and Biostatistics Program of the Miami CTSI. Dr. Messinger has previously served as Biostatistics Director for the Diabetes Research Institute and Director of Biostatistics for the University of Miami General Clinical Research Center, and eventually the School-supported Clinical Research Center. Dr. Messinger joined the faculty at the University of Miami in 2002, after earning her Doctorate in Biostatistics from the University of Michigan. She additionally holds a Master’s degree from the University of Florida in Industrial and Systems Engineering specializing in Operations Research and Health Systems Engineering. Her research includes investigations of serum microRNA as biomarkers for T1DM. Other research has been focused on islet transplantation, both in determining factors resulting in transplantable islet preparations as extensions into clinical practice of transplantation by identifying factors that are prognostic of eventual graft survival. She additionally collaborates in research investigations involving epidemiologic and intervention studies addressing primary and secondary prevention for persons at risk and living with HIV. Dr. Messinger regularly teaches courses in the Biostatistics and Epidemiology programs, as well as holds lectures to educate the research community on statistical issues related to clinical and translational research. Dr. Messinger serves on at the Committee on Applied Statisticians of the American Statistical Association, the Biostatistics Epidemiology Research Design Significant Interest Group of the CTSA Consortium, the Methods and Processes Direct Task Force of the CTSA Consortium, the Clinical Transplant Islet Registry Publication, and Presentation Committee, and is an active member of the Biometric Society. Field of Interest: Diabetes, Clinical Trials, Biomarkers & Clinical Biostatistics Curriculum Vitae Research Publications

University of Miami Miller School of Medicine Department of Public Health Sciences

Patricia I. Moreno, Ph.D., is an Assistant Professor in Department of Public Health Sciences at the University of Miami Miller School of Medicine and Lead of Evidence-Based Survivorship Supportive Care at the Sylvester Comprehensive Cancer Center. Dr. Moreno received a BA in Psychology & Spanish-Hispanic Studies from the University of Texas at Austin and an MA/PhD in Clinical Psychology from the University of California, Los Angeles (UCLA). She completed an APA-accredited internship in Cancer Behavioral Symptom Management and Support at the Duke University School of Medicine and an NCI-funded T32 post-doctoral fellowship in Cancer Control and Survivorship at the Northwestern University Feinberg School of Medicine. The overarching aim of Dr. Moreno’s research is to understand the significant challenges faced by patients coping with cancer and improve outcomes across the cancer continuum through patient-centered healthcare and tailored, empiricallysupported interventions. Her interests include resilience, metastatic disease, and supportive care needs, as well as psychoneuroimmunology and the pathways through which psychosocial factors influence stress biology. She is particularly interested in moving beyond a singular focus on distress and symptom reduction in order to elucidate the unique effects of protective psychological processes, such as purpose and meaning in life, acceptance, and positive emotion, on quality of life and health outcomes in cancer survivors. Due to persistent disparities experienced by racial and ethnic minorities, a primary area of Dr. Moreno's research focuses on identifying factors that can be targeted to improve quality of life and health outcomes among Hispanics/Latinos and other underrepresented, underserved individuals. In addition to her research activities, Dr. Moreno is a bilingual licensed clinical psychologist with more than ten years of clinical experience and more than seven years of experience providing evidence-based care to cancer survivors and their family members across three NCI-designated comprehensive cancer centers. Field of Interest: Cancer Control & Survivorship Curriculum Vitae Research Publications University of Miami Miller School of Medicine Department of Public Health Sciences

Dr. Amy Otto, Ph.D., is a Research Assistant Professor in the Division of Prevention Science and Community Health in DPHS at UMMSM. Dr. Otto joined the University of Miami Miller School of Medicine’s Department of Public Health Sciences from Moffitt Cancer Center, where she completed her postdoctoral fellowship after earning her Ph.D. in Clinical Psychology from the University of Delaware in 2018. Dr. Otto’s research focuses on psychosocial factors affecting well-being in cancer patients and their family caregivers, as well as the ways that patients and caregivers interact with the health care system. The goal of her research is to identify individual, relationship, and provider-or systems-level processes that are associated with psychological distress and health outcomes in patients and caregivers, identifying those most in need of intervention and ultimately informing the development of these interventions. Dr. Otto has co-authored a book chapter on biopsychosocial factors in gynecologic oncology, 15 peerreviewed publications, and has participated at numerous national scientific meetings. Field of Interest: Health & Well-Being in Cancer Survivors & Caregivers Curriculum Vitae Research Publications Ana M. Palacio, M.D., M.PH., is a clinician researcher and epidemiologist who completed the Internal Medicine residency at the University of Miami and a General Medicine Fellowship and Masters in Public Health at Johns Hopkins University. She joined the University of Miami as faculty in 2004. Since then her work has focused on the improvement of clinical outcomes among high risk adults through the implementation of innovative ancillary strategies, such as use of administrative data to identify those at risk, remote health coaching, point of care medication delivery, the collection and use of social determinants of health for risk stratification and prevention and the integration of multilevel data. 41

FACULTY BIOGRAPHIES CONTINUED She is a member of the Miami VA Geriatric Research, Clinical and Education Center. She is a local site PI for the Million Veteran Program and for VA-IMPACT, a multicenter trial that will compare Metformin and usual care at secondary prevention of cardiovascular outcomes. She is the lead evaluator and co-investigator in the U54 Precision Medicine and Health Disparities Collaborative. She is also Director of a faculty development program: the University of Miami Program in Research Education that coaches junior faculty in the conduction of clinical research. Field of Interest: Minority Health and Health Disparities Curriculum Vitae Research Publications Yue Pan, Ph.D., is a Research Assistant Professor in DPHS' Division of Biostatistics at the UMMSM. Dr. Pan’s research interests focus on examining social determinants and health disparities of substance use and HIV sexual risk behaviors among vulnerable populations, such as substance users, hospitalized HIV patients, men who have sex with men (MSM), and ethnicity minorities. Particularly, by adapting advanced statistical techniques such as Bayesian and Machine Learning, Predictive Modeling approaches to evaluate sexually transmitted disease (STD)/HIV prevention intervention, health behaviors, and health outcomes. Dr. Pan’s research interests also include clinical epidemiology and applied biostatistics analysis for chronic diseases such as alcohol use disorders, drug abuse, breast, and ovarian cancer, cardiovascular disease, and comorbidities. He also serves as an investigator in the National Institute on Drug Abuse (NIDA) Clinical Trials Network Florida Node Alliance and in the Clinic HIV/AIDS Registry of Miami (CHARM) Center focusing on mental health and HIV research. Field of Interest: Machine-Learning on HIV Prevention, Health Behaviors, and Outcomes Curriculum Vitae Research Publications University of Miami Miller School of Medicine Department of Public Health Sciences

Tatiana Perrino, Psy.D., is a prevention scientist dedicated to promoting child and adolescent mental health, particularly in communities disproportionately affected by these health concerns. She is a trained and licensed clinical psychologist who completed a National Institute on Drug Abuse post-doctoral fellowship in drug abuse prevention. She is a Professor, Educator, in DPHS at the UMMSM. For more than 20 years, Dr. Perrino has collaborated on research funded by the National Institutes of Health and Centers for Disease Control & Prevention to understand and reduce behavioral health disparities in HIV, drug abuse, obesity, and depression. Together with community stakeholders and public health students, Dr. Perrino works on programs that address mental, emotional and behavioral health problems in South Florida. Her current initiatives aim to strengthen resilience among socioeconomically disadvantaged youth through family and community-based interventions. Field of Interest: Promotion of Mental & Behavioral Health Curriculum Vitae Research Publications Paulo S. Pinheiro, Ph.D., is a Research Associate Professor of Epidemiology in DPHS at UMMSM, with over 15 years of experience in population-based cancer epidemiology. He trained as a resident physician in Portugal where he specialized in Public Health, then completed his MS and Ph.D. in Epidemiology in the Netherlands and Miami, FL, respectively, and completed two fellowships at the International Agency for Research on Cancer in France. His research interests primarily focus on cancer outcomes in Hispanic/Latino populations, and more recently, on Black/African-descent populations with an emphasis on revealing disparities in incidence, survival, and mortality masked by aggregating racial/ethnic groups. 42

In 2009, he pioneered the monitoring of cancer incidence in Hispanic subgroups (Mexicans, Cubans, Puerto Ricans) in the U.S. based on individual-level data from Florida. Subsequently, he has studied cancer in large and diverse Hispanic populations in Mexico, Colombia, California, New York, and Texas. Additionally, he has worked to improve cancer surveillance methodology and strives to achieve the most accurate characterization of cancer patterns in Latinos, thereby presenting a far more complex picture of the so-called “Hispanic Paradox”. Dr. Pinheiro has over 50 peer-reviewed publications, 15 of them as the first author, with more than 2000 citations to date. He has presented over 20 presentations in conferences on four different continents. Lastly, he has participated in NIH grant review panels for the Cancer Section and contributed to national reports and monograph initiatives from the National Cancer Institute, the American Cancer Society, and the Centers for Disease Control and Prevention. Dr. Pinheiro has served in the NIH study section CHSA 1 - Cancer Heart Sleep A. Field of Interest: Population-Based Cancer Epidemiology Curriculum Vitae Research Publications J. Sunil Rao, Ph.D., is Professor and Director of the Division of Biostatistics in DPHS at UMMSM. Previously, Dr. Rao served as Interim Chair of the department and was Professor of Biostatistics at Case Western Reserve University in Cleveland, Ohio. Dr. Rao’s research interests include high dimensional model selection, mixed model selection, predictive modeling, sparse bump hunting and development of statistical methods in cancer genomics. Dr. Rao teaches Generalized Linear Models in the M.S. and Ph.D. programs in Biostatistics. For external activities, Dr. Rao serves and has served on many editorial boards of statistics and bioinformatics journals, and served on various NIH grant review panels. He is also a fellow of the American Statistical Association. Field of Interest: Development of Statistical Methods Curriculum Vitae Research Publications University of Miami Miller School of Medicine Department of Public Health Sciences

Isildinha Reis, Ph.D., is a Research Professor in the Division of Biostatistics of DPHS at UMMSM and in the Biostatistics and Bioinformatics Core Shared Resource at the Sylvester Comprehensive Cancer Center. Dr. Reis is a member of the Sylvester’s Data and Safety Monitoring Committee (DSMC) and an alternative member of the Protocol Review Committee (PRC). She is also an affiliated-member of the Biobehavioral Oncology and Cancer Epidemiology (BOCE program and the BCR-designated statistician for both the Viral Oncology (VO) and the Molecular Targets and Developmental Therapeutics (MTDT) research programs as well as the breast cancer SDG. Dr. Reis earned her master’s degree in statistics from the University of São Paulo, Institute of Mathematics and Statistics, in 1989 and her DrPH in biostatistics in 1996 from the University of California at Los Angeles’ School of Public Health. Dr. Reis began her career as a statistician in a pharmaceutical company in São Paulo, Brazil in 1981 and then held a faculty position in the Biostatistics Division of the School of Public Health at the University of São Paulo for 10 years. Dr. Reis joined the University of Miami and Sylvester in 1999 as a Research Assistant Professor in the former Department of Epidemiology and Public Health and was promoted to Research Associate Professor in 2006. Dr. Reis served as Director of the Biostatistics Division of the Sylvester Biostatistics and Bioinformatics Core Shared Resource from 2012 to 2015. As a faculty biostatistician, Dr. Reis brings important statistical expertise to research projects at the University of Miami. Her ongoing collaboration with numerous Sylvester clinicians and research scientists includes clinical trials, basic-science research and translational investigations. Dr. Reis’ areas of special interest include survival analysis, repeated measures analysis, and statistical methods for planning and analyzing oncology clinical trials and clinical epidemiology studies. Dr. Reis regularly teaches a onesemester graduate course in survival analysis. Field of Interest: Statistical Methods for Clinical Trials & Predictive Models Curriculum Vitae Research Publications

FACULTY BIOGRAPHIES CONTINUED planning and analyzing oncology clinical trials and clinical epidemiology studies. Dr. Reis regularly teaches a onesemester graduate course in survival analysis. Field of Interest: Statistical Methods for Clinical Trials & Predictive Models Curriculum Vitae Research Publications James M. Shultz, Ph.D., MS, received his MS in Health Behavior Research in 1986 and his PhD in Behavioral Epidemiology in 1988 from the University of Minnesota. He joined the Department of Epidemiology and Public Health, University of Miami, in 1989 as an assistant professor and became a tenured associate professor in 1995. After leaving Miami in late 1999, he returned in 2002 as a voluntary associate professor, at the request of Dr. Clyde McCoy, to create a disaster training and research center in the department in the immediate aftermath of 9/11 (Center for Disaster and Extreme Event Preparedness—DEEP Center). Over a period of five years, DEEP Center conducted more than 500 full-day disaster behavioral health trainings for more than 20,000 participants nationwide. Dr. Shultz advises MD/ MPH students and has been the instructor for Introduction to the Science and Practice of Public Health since 2017 and for Interdisciplinary Health Communications since 2020. He also prepared and taught an elective course on the public health aspects of the unfolding COVID-19 pandemic in 2021. Dr. Shultz is the first author of a textbook entitled: Public Health: An Introduction to the Science and Practice of Population Health, co-authored by Dr. Sandro Galea, Dean, Boston University School of Public Health, a text that is used by both undergraduate and graduate public health programs nationwide. He is currently editing the Oxford Handbook of Complex Disaster Risks and Resilience. Dr. Shultz brings extensive expertise and scholarship in the areas of disaster public health, disaster behavioral health, and disaster complexity. His work has generated many collaborative opportunities for our students to present and publish on these University of Miami Miller School of Medicine Department of Public Health Sciences

topics. His research and commentaries in these areas have been published in a variety of journals including the NEJM, JAMA, Health Affairs, and multiple Lancet journals. On June 1, 2021, Dr. Shultz rejoined primary faculty in the Department of Public Health Sciences as Associate Professor, Educator Track. Field of Interest: Population Health, Disaster Public Health, Complexity Science, Substance Use Curriculum Vitae Research Publications Sara M. St. George, Ph.D., is an Assistant Professor in Prevention and Community Health Division in DPHS at UMMSM. She received her Ph.D. in ClinicalCommunity Psychology from the University of South Carolina and has expertise in pediatric obesity and its associated behaviors, including physical activity, sedentary behavior, and diet. Her research interests include developing and testing theoretically-based obesity prevention interventions which integrate multiple influential systems (e.g., family and peers) to promote positive health behaviors in ethnic minority adolescents. Throughout her graduate training, Dr. St. George developed the beginnings of an independent program of clinical research in pediatric obesity prevention and health promotion funded by a diversity supplement grant (NIH R01 DK 067615-02S1) and a pre-doctoral fellowship (NIH F31 HD 066944). This work lead to her receiving the Outstanding Dissertation Award from the Society of Behavioral Medicine. She was recently awarded a NIH K01 early career investigator award to continue to build from and expand her program of research. The goals of this study are to develop and pilot test a familybased intervention that combines the web and smartphone technology for increasing physical activity, decreasing sedentary behavior, and improving quality dietary intake in Hispanic adolescents. Dr. St. George is affiliated with both the Sylvester Comprehensive Cancer Center and the Center on Aging. She currently teaches Qualitative Research Methods in the Master’s and Ph.D. programs within DPHS. 44

Field of Interest: Obesity & Chronic Disease Curriculum Vitae Research Publications José Szapocznik, Ph.D., is a Professor in DPHS at UMMSM. He is Chair Emeritus of the Department of Public Health Sciences, Director of the Center for Family Studies, and Honorary Founding Director of the University of Miami-based Miami Clinical Translational. He has received over $120 million in NIH funding and had over 270 scholarly publications. Szapocznik has a profound interest in the role of context in development, behavior and health outcomes, dedicating his career to studying culture, family, neighborhood and the built environments as important contexts influencing minority populations. He pioneered the national effort to prevent and treat adolescent drug abuse and related behavior problems in Hispanic youth, developing and testing family-based, evidence-based approaches. He has also been a pioneer in the young field of the relationship between the human built environment and health outcomes, establishing a broadly interdisciplinary, university-wide team. As Contact PI of one of 13 NIDA-funded Nodes of the National Drug Abuse Treatment Clinical Trials Network (CTN), he has been a leader in the national initiative to translate effective drug abuse treatments into clinical practice by engaging the Network’s medical, community primary care and specialty drug treatment sites in conducting randomized clinical trials. Dr. Szapocznik has held a number of policy advisory roles including membership in the NIH National Advisory Councils for NIMH, NIDA, NIMHD, and the SAMSHA Center for Substance Abuse Prevention; and was a founding member and the first behavioral scientist to be appointed to the NIH-wide AIDS Program Advisory Committee (now the National Advisory Council for the NIH Office of AIDS). He served on Search Committees for the Directors of the FDA, NIMH, NIDA (3 times), and both SAMSHA Centers for Substance Abuse Treatment and Prevention.

University of Miami Miller School of Medicine Department of Public Health Sciences

Field of Interest: Brief Strategic Family Therapy Curriculum Vitae Research Publications Lily Wang, Ph.D., is an Associate Professor in DPHS at UMMSM. She is affiliated with the Sylvester Comprehensive Cancer Center and the John P. Hussman Institute for Human Genomics (HIHG). She is also the Co-Director of the HIHG Statistical and Bioinformatics Consulting Core in the HIHG Center for Genetic Epidemiology and Statistical Genetics. Previously, she was a tenured Associate Professor of Biostatistics at Vanderbilt University School of Medicine. Her research interest is to develop effective statistical models for the analysis of high -throughput genomics datasets. Her recent work includes development of mixed effects models for pathway-based analysis of gene expression datasets and genome-wide association studies. Over the past 11 years, Dr. Wang has also collaborated with clinical and basic science researchers on a variety of projects ranging from basic science and high-throughput genomics to clinical trials. Field of Interest: Epigenomics Data, Integrative Genomics Analysis & Systems Biology Curriculum Vitae Research Publications

FACULTY BIOGRAPHIES CONTINUED

University of Miami Miller School of Medicine Department of Public Health Sciences

Get To Know Us Department of Public Health Sciences Designed by Amanda Torres Revised on September 7, 2021

WWW.PUBLICHEALTH.MED.MIAMI.EDU WWW.GRADUATESTUDIES.PUBLICHEALTH.MED.MIAMI.EDU University of Miami Public Health Sciences @UMPublicHealth @umpublichealth

Department of Public Health Sciences 1120 NW 14th Street, CRB 918 Miami, FL 33136

University of Miami Miller School of Medicine Department of Public Health Sciences

Ph: 305-243-9105